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ABSTRACT OF DISSERTATION

ROLE OF THE REACTIVE OXYGEN SPECIES PEROXYNITRITE IN
TRAUMATIC BRAIN INJURY
Reactive oxygen species (ROS) is cytotoxic to the cell and is known to
contribute to secondary cell death following primary traumatic brain injury (TBI).
We described in our study that PN is the main mediator for both lipid peroxidation
and protein nitration, and occurred almost immediately after injury. As a
downstream factor to oxidative damage, the peak of Ca2+-dependent, calpainmediated cytoskeletal proteolysis preceded that of neurodegeneration,
suggesting that calpain-mediated proteolysis is the common pathway leading to
neuronal cell death. The time course study clearly elucidated the interrelationship
of these cellular changes following TBI, provided window of opportunity for
pharmacological intervention.
Furthermore, we conducted a pharmacological study to solidify our
hypothesis. First of all, we tested the potency of a membrane permeable,
catalytic scavenger of PN-derived free radicals, tempol for its ability to
antagonize PN-induced oxidative damage. Tempol successfully inhibited PNinduced protein nitration at dosages of 30, 100 and 300mg/kg. Moreover, early
single dose of 300mg/kg was administered and isolated mitochondria were
examined for respiratory function and oxidative damage level. Our data showed
that tempol reduced mitochondrial oxidative damage, and maintained
mitochondrial function within normal limits, which suggested that tempol is
efficiently permeable to mitochondrial membrane and mitochondrial oxidative
damage is essential to mitochondrial dysfunction. Next, we found that calpainmediated proteolysis is reduced at early treatment with a single dose of tempol.
However, the effect of tempol on calpain is short-lived possibly due to systematic
elimination. In our multiple dose study, tempol showed a significant inhibitory
effect on SBDPs. Consequently, we measured neuordegeneration with the de
Olmos aminocupric silver staining method at 7 days post-injury and detected a
significant decrease of neuronal cell death.
Together, the time course study and pharmacological study strongly
support the hypothesis that PN is the upstream mediator in secondary cell death
in the CCI TBI mouse model. Moreover, inhibition of PN-mediated oxidative
damage with the antioxidant, tempol, is able to attenuate multiple downstream

injury mechanisms. However, targeting PN alone may be clinically impractical
due to its limited therapeutic window. This limitation may be overcome in future
studies by a combination of multiple therapeutic strategies.
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Chapter One
Post-Traumatic Secondary Injury in Experimental Traumatic Brain Injury

Free Radicals Production and Oxidative Damage in Traumatic Brain Injury

Introduction
Oxygen is necessary for life. However, only about 85-90% of the O2 taken
up by mammalian cells is effectively utilized by their mitochondria for energy
production. The remainder is converted to highly toxic reactive oxygen species
(ROS) and their derived oxygen radicals which are damaging to cells. Following
acute traumatic brain injury (TBI), oxidative stress leading to the formation of
ROS and free radicals and oxidative alteration of brain tissue has been
implicated as a common pathway following excitotoxicity. Excitotoxicity begins
immediately after TBI, in which excessive excitatory amino acid, such as
glutamate, is released into extracellular spaces and over-activates glutamate
receptors, thereby inducing abnormal calcium influx (Faden, Demediuk et al.
1989). Moreover, other investigators showed that there is a prompt increase in
free radicals that is essentially coincident with the release of glutamate proximate
to the injury site, and there is a close correlation between the magnitudes of both
events, suggesting that these two processes are part of a common pathways
(Globus, Alonso et al. 1995). Furthermore, in vitro cortical cell culture studies
showed that application of free radical scavengers or antioxidant compounds
reduces glutamate-mediated excitotoxicity providing additional support for the
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role of oxidative stress and damage mechanisms in excitotoxicity (Monyer,
Hartley et al. 1990). However, oxidative stress is not the only component of posttraumatic cell death. Growing evidence has indicated that post-traumatic free
radical production is linked to disruption of intracellular calcium (Ca2+)
homeostasis, induction of mitochondrial dysfunction and loss of Ca2+ buffering
capacity and downstream activation of the Ca2+-dependent protease, calpain,
which can proteolytically dismantle cellular structure.
Brain tissue is particularly vulnerable to oxidative damage due to its high
metabolic requirement for oxygen; its prevalent concentration of oxidizable
polyunsaturated fatty acids (PUFAs) in membranes; its enrichment in redox
active metals, most notably iron and the presence of potentially phagocytic
microglia which can become a major source of ROS and free radicals when
activated by injury. The high content of free radical-sensitive PUFAs in the
membrane lipids of neurons and myelin provides the target for free radicalinduced lipid peroxidation (LP), in which a single free radical can trigger a chain
reaction in the lipid bilayer that is potentiated by transition metal ions (Hall and
Braughler 1993; Watson 1993).
Experimental TBI models have provided compelling evidence supporting
the important role of ROS and LP in the pathophysiology of acute TBI. The first
work showing this was provided by Kontos and his colleagues who demonstrated
an almost immediate post-injury increase in brain microvascular superoxide
radical production in fluid percussion injury (FPI) TBI model (Kontos and
Povlishock 1986; Kontos and Wei 1986). Moreover, hydroxyl radical was shown
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to increase during the first minutes after injury (Hall, Andrus et al. 1993), followed
in close succession by increased LP, blood-brain barrier (BBB) disruption and
edema (Smith, Andrus et al. 1994; Nishio, Yunoki et al. 1997; Kasprzak, Wozniak
et al. 2001). In addition to that, evidences from addition of exogenous
antioxidants and transgenic studies further suggest oxidative damage as a
potential therapeutic target (Hall and Smith 1991; Smith, Andrus et al. 1994;
Chan, Epstein et al. 1995; Mikawa, Kinouchi et al. 1996; Hall, Kupina et al.
1999).

Definition of Free Radical and ROS
As defined by Halliwell and Gutteridge, a free radical is any species
capable of independent existence (hence the “free”) that contains one or more
unpaired electrons. Free radicals may be mono- or poly-atomic. It is important to
know that not all free radicals are highly reactive. Reactive oxygen species
(ROS) is a collective term often used by scientists to include not only the oxygen
radicals (O2• ⎯ and •OH), but also some non-radical derivatives of O2 such as
hydrogen peroxide (H2O2). Therefore, some ROS are not necessarily a free
radical themselves, but are molecules that can generate free radicals (Halliwell
and Gutteridge et al, 1985). Moreover, some oxides of nitrogen are alternatively
termed reactive nitrogen species (RNS), such as nitric oxide (NO•) and
peroxynitrite anion (ONOO⎯).
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Oxygen as a Source of ROS
After brain injury, ROS and/or free radicals may be generated through
several different cellular pathways, such as the free radical leak from
mitochondria respiratory chain; nitric oxide synthases (NOSs); conversion of
xanthine dehydrogenase (XDH) to xanthine oxidase (XO); phospholipase A2cyclooxygenase pathway; Fenton and Haber-Weiss reactions by inflammatory
cells (Gutteridge and Halliwell 1989; Kehrer 2000). Moreover, a number of
enzymes,

such

as

cytochromes

P450,

various

oxidases,

peroxidases,

lipoxygenases and dehydrogenases can be sources of ROS.
Oxygen is the most abundant molecule in a biological system. It exists as
a di-radical and therefore is very reactive with radicals. Although oxygen can act
as an oxidizing agent, its two unpaired electrons remain at most stable state.
Thus O2 normally accepts one electron at a time, reacts sluggishly with nonradicals. As it is partially reduced through normal metabolic processes, oxygen is
often the source of free radicals. The escape of the free radicals normally is
counteracted by endogenous antioxidant system. However, under pathological
conditions, over-production of oxygen-derived ROS and free radicals overwhelms
the endogenous antioxidants, inducing “oxidative stress”. If the imbalance of the
pro- and anti-oxidant system occurs, this leads to degradation or modification of
macromolecules (e.g. lipids, proteins, nucleic acids) and irreversible impairment
of their function, it is termed as “oxidative damage”.
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Superoxide Radical
One of the most important sources of superoxide radical (O2• ⎯) in vivo is
the mitochondrial electron transport chain (ETC). Estimated up to 1% of total
mitochondrial oxygen consumption goes toward the production of superoxide or
hydrogen peroxide at intermediate steps of the mitochondrial ETC (Ischiropoulos
and Beckman 2003). It is believed that mono electron reduction of oxygen into
superoxide primarily occurs at ETC complex I (NADH dehydrogenase) level and
coenzyme Q level (ubiquinone-cytochrome b) (Kowaltowski and Vercesi 1999).
(Figure 1.1)

Succinate
Matrix

Fumarate

Complex II
Complex I
NADH
DH

IMM
NADH
O2

Complex
IV

Complex III
UQ• ⎯

UQ
O 2• ⎯

O2

Cyt c

NAD
O 2• ⎯

Figure 1.1 Simplified schematic of superoxide production from ETC.
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Theoretically, superoxide radical can be generated from oxygen through
mono electron reduction at all components of the respiratory chain. However, the
NADH dehydrogenase and ubiquinone-cytochrome b appear to be the two
primary O2• ⎯ generation sites (Turrens and Boveris 1980). Although complex IV
catalyses four sequential 1e⎯ additions to molecular oxygen, the intermediates
are tightly retained, and there is no leakage of superoxide occurs (Nicholls and
Ferguson et al. 2002). Physiologically, electrons are transferred from NADH to
the oxidized form of ubiquinone (UQ) to yield the reduced form of ubiquinone and
ubiquinol (UQH2). During the course when UQH2 transferring the electron to
cytochrome c oxdiase, it is converted to firstly intermediate free radical
semiquinone anion species (UQ• ⎯), and then back to UQ. This process initially
occurs on cytoplasmic face of the inner mitochondrial membrane (IMM), and is
then repeated on the matrix face of the IMM. Myxothiazol inhibits UQH2 at the
cytoplasmic face of the IMM, therefore blocks the formation of UQ• ⎯, and
stimulates O2• ⎯ formation only at the level of NADH dehydrogenase; whereas
antimycin A inhibits UQ• ⎯ formation at cytoplasmic face, thereby accumulates
UQ• ⎯ at matrix face of the IMM, resulting in stimulating O2• ⎯ formation at both the
level of NADH dehydrogenase and coenzyme Q. Therefore, some hypothesize
that mitochondrial generated O2• ⎯ preferably occurs at the lever of coenzyme Q
(Kowaltowski, Castilho et al. 1995). In contrast to that, complex I level of O2• ⎯
generation is more ∆Ψm dependent. However, the precise nature of the O2• ⎯
production site in complex I remain arguable. Complex I inhibitor rotenone
generates O2• ⎯ during electron transport through the complex from NAD+-linked
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substrates. Even with the absence of endogenous complex I substrates and with
succinate (complex II substrate), complex I can still generate O2• ⎯ as a result of
reversed electron transfer (Turrens and Boveris 1980). Therefore, NADH
dehydrogenase remains a notable site of O2• ⎯ generation.
Some O2• ⎯ is also produced by activated phagocytic cells. Activated
phagocytic cells are capable of reducing O2 into O2• ⎯ through the activity of
NADPH oxidase (Bianca, Dusi et al. 1999; Gao, Jiang et al. 2002). Another
source is the largely endothelial cell-contained xanthine oxidase (McCord 1987).
Most of the xanthine/hypoxanthine oxidation in vivo is catalysed by xanthine
dehydrogenase, which transfers electrons from the substrates onto NAD+ rather
than to O2.
Xanthine/hypoxanthine
+
NAD+

Xanthine dehydrogenase

Uric acid
+
NADH

However, under ischemic and post-ischemic reoxygenation conditions, xanthine
dehydrogenase can be converted into xanthine oxidase by oxidation and
therefore produce O2• ⎯ and H2O2 while oxidizing xanthine or hypoxanthine. In
addition to that, depletion of adenosine triphosphate (ATP) in hypoxic tissues
results in accumulation of hypoxanthine. Hypoxanthine can be oxidized by
xanthine oxidase when tissue are reoxygenated, causing rapid generation of O2• ⎯
and H2O2.
Superoxide radical can also be produced by heme proteins. Normally, the
iron in the heme rings of the hemoglobin or myoglobin remains in the ferrous
state (Fe2+) for O2 binding. However, some delocalization of the electron takes

7

place and results in an intermediate structure, producing ferric iron (Fe3+) in the
heme ring. Ferric iron present in the heme ring is inactive and unable to bind O2,
thereby releases a molecule of superoxide radical:
Heme–Fe2+–O2 ↔ heme–Fe3+–O2• ⎯ → O2• ⎯ + heme–Fe3+
Moreover, superoxide can be produced from arachidonic acid cascade
through prostaglandin hydroperoxidase (PGH) and 5-lipoxygenase activity as a
side-chain reaction depending on the presence of NADH or NADPH (Kukreja,
Kontos et al. 1986).
There are several important biological oxidations in the presence of O2
that result in O2• ⎯, such as glyceraldehyde, FMNH2, FADH2, the hormones
adrenalin

and

noradrenalin,

L-DOPA

(dihydroxyphenylalanine),

the

neurotransmitter dopamine, tetrahydropteridines and thiol compounds (eg.
cysteine) (Davis, Kaufman et al. 1988). Most of these reactions are accelerated
by transition metals since O2 is poorly reactive.
More interestingly, Ca2+ influx was suggested to be a source of
mitochondrial O2• ⎯ as well, in which Ca2+ leads to IMM alteration and
disorganization of the ETC (Kowaltowski, Castilho et al. 1995). Grijalba et al
proposed that Ca2+ alters the lipid organization of IMM by interacting with the
anionic head of cardiolipin, which is an abundant component of IMM. As a result,
the function of the ETC was affected, such as coenzyme Q mobility, leading to
mono-electronic oxygen reduction at intermediate steps of respiration, which
promote the production of O2• ⎯ (Grijalba, Vercesi et al. 1999).
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To this end, superoxide can reduce the endogenous antioxidant enzyme
reservoir by direct reaction, such as with catalase and glutathione peroxidase, as
well as enzymes involved in energy metabolism (Zhang, Marcillat et al. 1990).
Nevertheless, neither O2• ⎯ nor H2O2 is sufficiently reactive to account for much of
the post-traumatic oxidative damage found in vivo. It is known that superoxidederived species are much more cytotoxic than superoxide itself.

Superoxide-Derived Species
Hydroperoxyl radical: While O2• ⎯ may act as an oxidant or reductant, and
is reactive with radicals, for example, reduce Fe3+ to Fe2+, it is relatively inert in
reaction with non-radicals in aqueous environments. In solution, superoxide
exists in equilibrium with its protonated form, hydroperoxyl radical (HO2•). Under
conditions of tissue acidosis occur within severely injured nervous system, O2• ⎯
exists mostly as HO2•, which is more reactive and capable of initiating LP
(Halliwell, Gutteridge et al, 1985). In contrast to the exceedingly slow rate of
dismutation of O2• ⎯ to H2O2, HO2• is much more readily able to generate H2O2
(Hall and Braughler 1993).
O2• ⎯ + H+ → HO2•
Hydrogen peroxide: Dismutation of O2• ⎯ by superoxide dismutase (SOD)
generates hydrogen peroxide (H2O2). SOD is an important antioxidant enzyme
and specific for O2• ⎯ as a substrate. However, H2O2 is poorly reactive at
physiological level. H2O2 is usually removed by two types of enzymes: catalases
and peroxidases. The catalases directly catalyse decomposition of H2O2 to O2:
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2 H2O2 → 2 H2O + O2. Peroxidase enzymes remove H2O2 by using it to oxidize
another substrate: SH2 + H2O2 → S + 2H2O. In the case of glutathione
peroxidase (GPX), it removes H2O2 by coupling its reduction to H2O with
oxidation of reduced glutathione (GSH): H2O2 + 2GSH → GSSG + 2H2O. Both
catalases and GPX enzymes are widely distributed in animal tissues readily to
produce H2O2.
Hydroxyl radical: Hydroxyl radical (•OH) is an extremely reactive form of
free radicals produced from H2O2 by the metal-catalyzed Fenton reaction; or in
the presence of O2• ⎯ and catalytic amounts of transition medals, from the metalcatalyzed Haber-Weiss reaction (Gutteridge and Halliwell 1989).
Mitochondria
•
O2 ⎯

Phagocytes

SOD

H2O2 + Fe2+

Action of
Other enzymes

Fe3+ + OH⎯ + •OH

Oxidative damage

O2• ⎯

O2

Hydroxyl radical can also be produced from peroxynitrite (PN), a ROS generated
by reaction between nitric oxide (NO•) and superoxide radical (O2• ⎯) (Radi,
Beckman et al. 1991). Hydroxyl radical was detected within half an hour after
trauma through the use of trapping agents such as salicylate (Hall, Andrus et al.
1993) or nitrone spin traps (Sen and Phillis 1993; Sen, Goldman et al. 1994). The
formation of highly reactive •OH became widely accepted as the primary
mechanism of free radical toxicity. Although •OH is capable of destroying various
bio-molecules, the reaction with organic molecules is diffusion rate-limited,
ranging from 109 to 1010 M-1•s-1. Therefore, it will react as fast as it is formed and
cannot explain any form of oxidative damage that occurs remote from its site of
10

formation. Thus, Its “non-discriminative” nature makes •OH attack uncritical
targets and quickly be removed from the system (Hall and Braughler 1993;
Beckman 1994; Crow and Beckman 1996).
Peroxynitrite: To better understand the toxicity of oxidative damage, an
oxidant that is able to out-compete endogenous antioxidant defenses is proposed
to be peroxynitrite (Blou 1985; Beckman 1994). Peroxynitrite (PN) refers to
peroxynitrite anion (ONOO⎯) as well as its conjugate acid, peroxynitrous acid
(ONOOH). PN is produced by the very fast reaction of O2• ⎯ with NO•.
Interestingly, O2• ⎯ is one of the few molecules that reacts with NO• quickly. PN
can generate a wide range of noxious free radical species under physiological
conditions. Superoxide radical and nitric oxide react readily at rate of 6.7 × 109 M1

•s-1, which is at least three times faster than SOD reacts with O2• ⎯, and at least

ten times faster than heme compounds react with NO•. Therefore, NO• and O2• ⎯
can antagonize each other’s biological actions (Cudd and Fridovich 1982; Huie
and Padmaja 1993).
NO• + O2• ⎯

ONOO⎯

k ≈ 7 × 109 M-1•s-1

In humans, NO• is formed from arginine, O2 and NADPH by nitric oxide
synthases (NOSs) and functions as a diffusible messenger to modulate neuronal
signaling following excitotoxicity (Garthwaite, Charles et al. 1988), regulate
vascular tone, and kill pathogens (Bredt and Snyder 1990; Bredt and Snyder
1994).
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NADPH
Arginine

½ NADPH
hydroxy-arginine

O2

H2O

O2

citrulline + NO•
H2O

There are three identified isoforms of NOS, which are endothelial NOS (eNOS),
neuronal (nNOS) and inducible (iNOS), all of which appear to be involved in TBI
pathology. For instance, it was shown in a lateral FPI model, that there was a
pronounced eNOS increase in microvessels surrounding the cortical contusion at
24 hrs after injury which was associated with BBB breakdown and hyperemia
(Cobbs, Fenoy et al. 1997). Moreover, studies using NOS inhibitors showed
reduced neurological deficit, which suggested a possible important pathological
role of NO• and PN in neurodegeneration following TBI. However, the drug
effects appeared to be time dependent and showed a limited therapeutic time
window after injury (Mesenge, Verrecchia et al. 1996; Wada, Chatzipanteli et al.
1998). In comparison to that, iNOS activity was also shown to be significantly
increased, and improved histopathological outcome has been reported following
inhibition of iNOS in a FPI model (Wada, Chatzipanteli et al. 1998). Nevertheless,
the levels of all three NOS appeared to have different temporal and spatial
profiles, indicating the compartmentalization of nitric oxide can be beneficial or
detrimental (Gahm, Holmin et al. 2000; Orihara, Ikematsu et al. 2001). In recent
years, a novel isoform of NOS was described located within mitochondria, named
mitochondrial NOS (mtNOS) (Bates, Loesch et al. 1995; Lopez-Figueroa,
Caamano et al. 2000). It was suggested to play a role in calcium release by
formation of intramitochondrial PN through thiol cross-linking and NAD+
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hydrolysis to prevent calcium overload (Bringold, Ghafourifar et al. 2000).
However, overproduction of intramitochondrial NO•-derived PN was indicated to
induce irreversible damage to neuron-mitochondrial complex (Stewart, Sharpe et
al. 2000).
PN has relative long half-life compared to other ROS (~1sec), and it can
diffuse across membrane, which enable PN to induce oxidative damage remote
from its site of formation. The protonated form of PN (around neutral pH),
peroxynitrous acid (ONOOH), is a strong oxidizing species. ONOOH is unstable
and quickly releases nitrogen dioxide (•NO2) and hydroxyl radical (•OH).
Moreover, PN can also react with carbon dioxide (CO2) to form nitrosoperoxo
carbonate (ONOOCO2), then breaks down into nitrogen dioxide (•NO2) and
carbonate radical (CO3• ⎯). PN-derived radicals are extremely potent and react
rapidly with bio-molecules (Murphy, Packer et al. 1998; Radi 1998; Hall, Detloff et
al. 2004). (Figure 1.2)
One of the most studied reactions involved in PN biochemistry concerns
the conversion of 3 position tyrosine to 3-nitrotyrosine (3NT), in which PN-derived
•NO2 nitrates aromatic compounds, which is widely used as a bioassay to detect
ONOO⎯ in vivo (Beckman 1996). In addition to that, PN-derived radicals can
induce LP which produces various aliphatic aldehydic products which bind to
cellular proteins and be measured by immunohistochemistry (Hall, Oostveen et
al. 1997; Hall, Detloff et al. 2004). Moreover, 4-hydroxynonenal (4HNE) is the
most cytotoxic LP-derived aldehydes (Keller, Mark et al. 1997).
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Figure 1.2 Biochemistry of ROS formation.
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Neuronal Tissue Oxidative Damage
Oxidative damage to lipids: As noted earlier, due to its high content in
PUFAs, brain tissues are very susceptible to LP. A species that can sufficiently
react to abstract a hydrogen atom from a methylene (–CH2–) group can initiate
LP. In the case of fatty acids with no or one double carbon-carbon bonds, they
are more resistant to such attack. However, in the case of PUFAs, the adjacent
double bonds weaken the energy of the attachment of the hydrogen atoms
present on the next carbon atom (termed allylic hydrogen), particularly when
there is a double bond on both sides of the methylene, giving bis-allylic
hydrogen. As a consequence, the commitment of this carbon to bind with the
hydrogen atom on it becomes very ambivalent. Therefore, if a free radical comes
along, it can easily remove the hydrogen atom and the electron associated with
it. As a result, the free radical is quenched, while the PUFA is turned into a free
radical, termed alkyl radical (L•). However, LP is a geometrically progressing
process. The allylic radical can then react with molecular oxygen (O2) and form
lipid peroxyl radical (LOO•). If this process is not ceased by endogenous
antioxidant compounds or enzymes, the lipid peroxyl radical will react with other
PUFAs to form a second allylic radical, while becoming a lipid hydroperoxide
(LOOH). If there is transition metal ion (Fe2+/Fe3+) comes along, the LOOH
undergoes decomposition to create an alkoxyl radical (LO•) or a peroxyl racial
(LOO•). Either lipid radical can attack neighboring fatty acids and thus the
process of peroxidation propagates throughout the membrane (Figure 1.3).
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Figure 1.3 Chemistry of initiation and propagation phases of cell membrane LP.
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As a result, LP decreases membrane fluidity, increases permeability of the
membrane bilayer to various substances that are normally impermeable and
inactivates certain membrane-bound enzymes. The continuation of oxidation of
fatty acid side chains and their fragmentations to produce aldehydic breakdown
products eventually leads to the loss of membrane integrity. Moreover, the
products of LP, such as peroxyl radicals, alkoxyl radicals and aldehydes
(especially 4-hydroxylnonenal) can induce severe damage to proteins. For
example, 4HNE, an end-product of LP, can conjugate onto proteins causing toxic
protein aggregates within membranes(Keller, Mark et al. 1997; Kruman, BruceKeller et al. 1997).
Varieties of superoxide-derived radicals are capable of inducing LP. Acidic
pH conditions, which is known to occur within severely injured neuronal tissues,
accelerates superoxide radical to conjugate with H+ to form hydroperoxyl radical
(HO2•), which is more soluble and much more reactive. As a defense antioxidant
mechanism, the rate of O2• ⎯ endogenous dismutation into H2O2 is also increased.
Normally in brain tissues, low molecular weight forms of redox active iron are
retained, as in other tissues, at extremely low or none levels. Although iron
storage proteins at neutral pH, such as ferritin and transferrin, have high affinity
for iron, they are readily to give up iron under acidic conditions. The irons
released from iron-binding proteins participate in catalyzing LP, in which the most
studied iron-catalyzed redox reaction is Fenton reaction:
Fe2+ + H2O2

Fe3+ + •OH + OH⎯

Fe2+ + H2O2

Fe3+OH + OH⎯
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Both •OH and Fe3+ are extraordinary potent oxidants and capable of initiate
damage to lipids, proteins and DNAs. On the other hand, Haber-Weiss reaction
may also occur in the presence of transition metals to generate oxidizing
radicals, though it has a second-order rate constant in aqueous solution of nearly
zero.
H2O2 + O2• ⎯

O2 + OH⎯ + •OH

Fe3+ + O2• ⎯

Fe2+ + O2

Fe2+ + H2O2

Fe3+ + •OH + OH⎯

In addition to iron-dependent radical production, PN-derived •NO2, CO3• ⎯ and
•OH (Figure 1.2) are potent oxidants that capable of inducing intensive tissue
damages.
Since LP is a complex process with multiple stages, there are many LP
measurement techniques are available for measuring the rate of peroxidation of
membrane lipids, lipoproteins or fatty acids. One of the most preferred methods
is to measure the aldehyde “end-products” of peroxidation, among which 4HNE
is one of the most cytotoxic aldehydes. Reactive aldehyde, such as 4HNE, binds
rapidly to proteins, therefore antibody-based immuno-detection of such adducts
within cells and tissues is considerable. Moreover, immuno-histochemical
procedure can locate the distribution of such adducts in tissue slices subjected to
oxidative damage.
Oxidative damage to proteins: Damages to proteins can be induced
directly by ROS, as well as indirectly by end product of LP, such as
malondialdehyde (MDA) and 4HNE through rapid reaction with thiol (–SH–)
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groups at physiological pH. Attach of RNS, such as ONOO⎯, •NO2 and NO2Cl,
leads to 3NT formation. Moreover, •OH or singlet O2 can generate multi endproducts upon proteins. By contrast, H2O2 and O2• ⎯ at physiological level have
little or no direct effect on proteins. Protein oxidation can lead to specific damage
to certain amino acid residues. As a result, not only enzymes, but also receptor
proteins and transport proteins can become a target of oxidative damage.
The “general” assay of oxidative protein damage is carbonyl assay. The
rationale is based on the fact that several ROS attack amino acid residues to
generate products with carbonyl groups, which can be measured after reaction
with 2,4-dinitrophenylhydrazine (DNPH). The immuno-detection is designed to
recognize the protein with carbonyl group that is conjugated to DNPH.
Oxidative damage to DNAs: Oxidative damage to DNAs can lead to strand
breakage, damage to the deoxyribose sugar and modification of the purine and
pyrimidine bases. However, nuclease activity occurs during DNA repair can also
induce strand breakage, but cannot be equated to oxidative DNA damage. The
most common assay is to measure 8-hydroxydeoxyguanosine (8-OHdG), 8hydroxyguanine (8-OH-G) attached to deoxyribose, which is formed by •OH
attacking upon DNA followed by mono-electron oxidation of the resulting radical.
Guanine in DNA

•OH

[8-OHdG]•

– 1e⎯

8-OHdG

However, the intermediate [8-OHdG]• radical may have alternative fates.
Therefore, the measurement of a single product of the amount of hydroxylated
guanine in DNA does not sufficiently indicate the amount of initial radical attack.
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Moreover, DNA is more susceptible to oxidative damage if it is exposed to H2O2
(Schraufstatter, Hinshaw et al. 1986).

Mitochondrial Dysfunction in Traumatic Brain Injury

As noted previously, excitotoxicity is a pathological process results in
neuronal cell death through which the over-activation of receptors for the
excitatory neurotransmitter, glutamate. N-Methyl-D-aspartate (NMDA) receptors
are a subclass of glutamate receptors that play an essential role in Na+ and Ca2+
influx into the cell (Faden, Demediuk et al. 1989). Na+ gradient cross the plasma
membrane is required for glutamate uptake. NMDA over-activation will
exacerbate glutamate accumulation extracellularly and hence Ca2+ influx by
inducing Ca2+ channels. The unique features of mitochondria allow them to
accumulate calcium when the intracellular [Ca2+]i reaches a “set-point” of 500nm
in order to modulate Ca2+ homeostasis in the cytosol (Schinder, Olson et al.
1996; Nicholls and Ferguson et al. 2002). Mitochondrial dysfunction in regards to
its Ca2+ buffering capability is an essential mediator of excitotoxicity. Specifically,
excessive mitochondrial Ca2+ accumulation uncouples electron transfer from ATP
synthesis leading to mitochondrial dysfunction (Beatrice, Palmer et al. 1980;
Gunter and Pfeiffer 1990; Bernardi, Broekemeier et al. 1994).
The disturbance of energy metabolism during Ca2+ overload can result in
an increase in the mitochondrial leak of oxygen radicals, which can overwhelm
the antioxidant defense mechanisms and contribute to cell death (Halliwell and
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Gutteridge et al. 1989; Coyle and Puttfarcken 1993; Lang-Rollin, Rideout et al.
2003). Oxidants are constantly generated even during normal metabolism as the
intrinsic rate of proton leakage across the IMM increases, such as O2•⎯, H2O2,
•OH (Shigenaga, Hagen et al. 1994). There are array of cellular anti-oxidant
defenses that antagonize the production of oxidants. However, in a variety of
pathological conditions, such as TBI, the rate of ROS production within
mitochondria is exacerbated. The main sites for superoxide production are
suggested to be complex I and complex III of the ETC (Turrens and Boveris
1980; Sugioka, Nakano et al. 1988). However, the precise nature of the ROS
production sites in complex I remain obscure. It was also indicated that Ca2+
influx induces IMM lipid re-organization by interacting with the anionic head of
cardiolipin, which is an abundant component in IMM. As a result, mono-electron
was delivered to oxygen at intermediate steps of respiration, which result in the
production of O2• ⎯ through ETC (Grijalba, Vercesi et al. 1999). In addition to that,
NO• production is also detected intramitochondrially through the activation of an
isoform of NOS located within the mitochondria. It was suggested that this
isoform of NOS is activated upon Ca2+ uptake (Giulivi 1998; Tatoyan and Giulivi
1998). Like the three main isoforms of NOS, diversity in its function and location
gives it a unique role in mitochondria, such as a feedback signal to prevent
overloading of Ca2+ and decreasing mitochondrial membrane potential (∆Ψm)
(Ghafourifar and Richter 1997). Although NO• is believed to have potential toxic
effect, many of them are more likely mediated by PN and its oxidation products
rather than NO• by itself, such as PN (Bringold, Ghafourifar et al. 2000; Stewart,
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Sharpe et al. 2000). Evidence showed that the NO•-dependent inactivation of
iron-sulfur centers was in fact mediated by PN (Castro, Rodriguez et al. 1994;
Hausladen and Fridovich 1994). Together, mitochondria provide a favorable
environment for PN-induced oxidative damage in response to Ca2+ uptake.
Moreover, post-traumatic excessive mitochondrial uptake of Ca2+ can lead
to a sudden increase in inner membrane permeability to compounds with a
molecular mass less than 1.5kD, defined as the formation of mitochondrial
permeability transition pore (mPTP). The mPTP formation is believed to be the
basis of mitochondrial swelling and metabolic failure and ultimately cell death
(Zamzami, Hirsch et al. 1997). Although it is considered to be a non-specific
membrane opening, evidence showed that the onset of the mPTP can be
prevented by the immunosuppressant cyclosporine A (CsA) suggesting that it is
more than a non-specific membrane rupture (Bernardi, Broekemeier et al. 1994;
Bernardi 1996; Nicolli, Basso et al. 1996; Sullivan, Thompson et al. 1999).
Multiple studies have indicated that the oxidation of mPTP components occurs
and may play a major role in promoting mPTP formation. It was shown that
mitochondrial Ca2+ release could be simulated in response to the oxidation of
mitochondrial pyridine nucleotides, and be inhibited (or reversed) by NAD(P)+
reduction (Lehninger, Vercesi et al. 1978). Pro-antioxidants that deplete
glutathione and promote pyridine nucleotides oxidation also resulted in mPTP
formation and cell death; whereas diminishing pyridine nucleotide oxidation and
oxidative stress delayed the onset of mPTP and cell death (Nieminen, Byrne et
al. 1997). Some evidence has indicated that mPTP occurs when thiol groups of
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inner membrane proteins are oxidized, which leads to conformational changes. In
studies on PN-induced protein thiol oxidation, mPTP is paralleled by membrane
lipid oxidation (Packer and Murphy 1995; Gadelha, Thomson et al. 1997). In
addition, thiol-specific antioxidants protect against mPTP (Kowaltowski, Netto et
al. 1998). Other research indicated that the oxidation of adenine nucleotide
translocator (ANT), an important component of mPTP, through thiol groups
cross-linking, can facilitate mPTP formation, probably by enhancing cyclophilin
(CypD) binding, and preventing adenosine diphosphate (ADP) binding (McStay,
Clarke et al. 2002; Sullivan, Rabchevsky et al. 2004). Skulachev et al
hypothesized a reason for mPTP would be to ameliorate or eliminate high ROS
producing cells as a defense system in order to prevent further oxidative damage
(Skulachev 1996). In this hypothesis, mPTP formation assists maximal O2
consumption and decreases mitochondrial O2 concentration through dissipating
membrane potential (∆Ψm) and proton force (∆pH) across the membrane upon
Ca2+ influx. In other words, it was suggested that elevated mitochondrial ROS
production plays a regulatory role of oxidative stress to induce “mild” uncoupling
of mitochondrial respiration and phosphorylation by means of increase in proton
leak of IMM to promote respiration and ameliorate further ROS production.
Nevertheless, complete uncoupling of mitochondrial respiration and ADP
phosphorylation or prolonged uncoupling through mPTP will exhaust ADP in the
matrix, which increases O2 concentration because of the inhibition of respiration.
Highly oxidized mPTP will not be able to recover and result in disruption of
mitochondrial membrane, eventually lead to calcium disturbance as well as
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release of pro-apoptotic proteins, such as cytochrome c (Cyt c), Smac/DIABLO
and apoptosis inducing factor (AIF), due to rupture of outer mitochondrial
membrane (Sullivan, Keller et al. 2002; Halestrap and Brennerb 2003; Green and
Kroemer 2004; Sullivan, Springer et al. 2004).

Calpain-Mediated Cytoskeletal Proteolysis in Traumatic Brain Injury

Calpain Isoforms:
Following TBI, excitotoxicity inducing excessive calcium influx was shown
to be associated with cell damage. Non-physiological [Ca2+]i rise can exert
adverse effects by over-activating cellular proteases and lipases (Wrogemann
and Pena 1976). One of those has been indicated under multiple pathological
conditions and contributing to cell damage is calpain. Calpains are family of
calcium-activated cysteinyl/thiol (neutral) proteases, in which cysteine residues
are present in its active site. The calpain family consists of several tissue-specific
isoforms (n-calpains) and two ubiquitous isoforms (µ-calpain and m-calpain).
Calpains are expressed in all vertebrates in which they are highly conserved
across species. They are also found in various cell types and tissues (Sorimachi,
Ishiura et al. 1997). The two ubiquitous calpain isoforms are categorized mainly
on the basis of their sensitivity to [Ca2+] upon activation in their purified state in
vitro. First of all, µ-calpain (aka. calpain I) has micro-molar sensitivity to calcium
and is located primarily in the neuronal soma and dendrites. m-Calpain (aka.
calpain II) has a millimolar sensitivity to calcium activation and is primarily located
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in axons and glia. Moreover, because of the distinct subcellular localization of the
calpain subtypes, they may serve specific physiological roles (Hamakubo,
Kannagi et al. 1986). More interestingly, µ-calpain, which has higher affinity for
calcium binding, has been shown to located in mitochondria (Garcia, Bondada et
al. 2005).

Evidence for a Role of Calpain in TBI:
Growing interests in calpain due to, in many neurodegenerative diseases,
etiologic factors such as excitotoxicity, free radical injury and mitochondrial
homeostasis all lead to disturbance of intracellular Ca2+ level. As one expected
effect of disruption of Ca2+ homeostasis is the activation of Ca2+-dependent
lipases and proteases. Among which, calpain family is believed to be very
important since they proteolysis important enzymes, including protein kinases,
phosphatases, and modify structure proteins of membrane skeleton (Nixon
1989). In order to detect calpain activity, protease inhibitors that block calpains
have been used in experimental TBI models to investigate their activation. These
inhibitors have been shown to be neuroprotective in vivo as well as in vitro in
cerebral ischemia (Bartus, Hayward et al. 1994) and TBI models (Saatman,
Murai et al. 1996; Posmantur, Kampfl et al. 1997; Kupina, Nath et al. 2001;
Kupina, Detloff et al. 2002). However, due to the uncertain selectivity of these
inhibitors for calpain proteases, these data have only provided indirect evidence
for calpain activity after acute CNS injury. Moreover, subunit autolysis seems to
be an early event in the intramolecular activation of µ-calpain (Saido, Nagao et
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al. 1992). The ratio of the activated, autolyzed 76kD isoform to the 80kD
precursor form has been used as an index for µ-calpain activation. Nevertheless,
others reported that µ-calpain activation does not require autolysis (Edmunds,
Nagainis et al. 1991). Kampfl et al showed that µ-calpain autolysis was only
temporally correlated with calpain-mediated α-spectrin breakdown products
(Kampfl, Posmantur et al. 1996)
A more commonly used method of measuring calpain activity is to detect
the presence of breakdown products (BDPs). Preferred substrates for calpain
include cytoskeletal proteins spectrin, microtubule-associated proteins (MAP2)
and neurofilament proteins (NF), which are major components of neuronal
cytoskeleton and membrane (Saatman, Graham et al. 1998). Posmantur et al
indicated that the occurrence of the loss of neurofilament 68 and low molecular
weight BDPs associates with TBI (Posmantur, Hayes et al. 1994). Moreover,
unlike other proteases, such as cathepsins and trypsin, calpain produces
distinctive breakdown fragments that resemble the patterns observed after TBI.
More direct evidence of calpain activity is measured by antibody-based immunodetection of calpain-mediated α-spectrin breakdown and it is widely used in
models of TBI (Saatman, Bozyczko-Coyne et al. 1996; Kupina, Detloff et al.
2002; Hall, Detloff et al. 2004). The α-spectrin breakdown products (SBDPs) are
produced by both calpain and another cysteine protease, caspase 3. Given that
the activation of calpain as well as apoptotic enzymes is implicated in different
neuronal cell death cascades, SBDPs became a useful tool to study both
proteases in the same model. Calpains are shown to be involved in both necrosis
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and apoptosis, while caspases are largely involved in apoptosis (Wang 2000).
Spectrin, as a major constituent of the skeletal network, is a common substrate of
both calpain and caspase 3, the downstream factor of apoptotic cascade. The
breakdown of the 280kD protein α-spectrin by either calpain (145kD product) or
calpain and/or caspase 3 (150kD product) can be detected using antibody-based
immuno-detection (Wang 2000; Kupina, Detloff et al. 2003; Deng, Thompson et
al. 2007). The neuronal cytoskeleton is an important component maintaining cell
architecture, as well as axonal transport, and possibly neuronal plasticity (Ludin
and Matus 1993). Following experimental acute TBI, evidence has shown
significant proteolysis of dendritic MAP2 (Taft, Yang et al. 1992). Immunohistochemical studies revealed that SBDPs indication of calpain activity occur in
apical dendrites following TBI (Saatman, Bozyczko-Coyne et al. 1996).
Moreover, it is shown that NF compaction is associated with proteolysis of NF
sidearms following traumatic axonal injury (TAI) (Okonkwo, Pettus et al. 1998).
However, calpain-mediated proteolysis seemed to be involved more with the
axons that are located in areas with the most severe injury sustained from an
impact, whereas areas that are with less severity show no calpain-mediated
change (Saatman, Bozyczko-Coyne et al. 1996). Above all, increasing evidences
point to the important role of calpain in cytoskeletal de-arrangement and
degradation, therefore, its possible occurrence in sublethally injured cells.
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The Relationship of Oxidative Damage, Mitochondrial Dysfunction, Calpain
Activation and Neurodegeneration in Traumatic Brain Injury

TBI is one of the leading causes of serious disability and death in children
and adults. Different severities of TBI from mild, moderate to severe cases can
all lead to neurological, economical and social burden to not only the patients but
also the families and the society as a whole (Thurman, Alverson et al. 1999). The
number of treated cases keeps increasing over the years. To this day, there are
no clinically proven and FDA approved pharmacological treatments for acute TBI
patients. Although improved specialized paramedics and emergency treatments
saved lives on scene that otherwise may die, many patients survived the injury
continuously suffered from physical, cognitive, emotional and behavioral deficit
that severely impair their quality of life. It is now understood that most of the
neurological damage is not the immediate result from the acute mechanical
impact,

but

rather

an

outcome

of

an

evolving

pathochemical

and

pathophysiological process following the initial injury over minutes, hours and
days. However, growing evidences from scientific experiments suggests that
pharmacological treatments targeting these post-traumatic neurochemical
changing may lead to a better neurological and behavioral outcome. This
provides hope in the attempt to not only save lives, but also ensure a better
quality of life after injury.
In order to examine mechanistic hypothesis and to test preclinical
therapeutics, experimental animal models are essential in scientific investigations
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(Lighthall, Dixon et al. 1989). In our study, we applied a mouse uni-lateral
controlled cortical impact (CCI) model of TBI, which is widely used in scientific
studies. This CCI model yields consistent neurochemical, histological and
behavioral deficits (Huh, Laurer et al. 2002; Hall, Gibson et al. 2005; Hall,
Sullivan et al. 2005; Deng, Thompson et al. 2007; Onyszchuk, Al-Hafez et al.
2007). In this model, a fully anesthetized mouse was placed underneath a
computer-controlled pneumatic piston. We firstly produced a craniotomy
positioned between bregma and lambda lateral to sagittal suture. Secondly, the
pneumatic piston produced a cortical contusion with pre-set parameters. Finally,
the skin was sutured and the animals were physiologically monitored until regain
consciousness. The mice recovered well with minimal mortality. Furthermore, this
model has reproducible gross histological lesions and allows multiple outcome
measurements. Also, this model can produce different severity of injury that is
easy to use, affordable and sensitive to intervention.
The post-injury secondary cell death cascade is a multi-factorial process.
Based on the current state of knowledge, three of the most critically important
pathological elements are ROS formation, mitochondrial dysfunction and
cytoskeletal degradation. As indicated previously, these injury processes are
potentially interwoven: primary injury triggered excitotoxicity inevitably induces
abnormal intracellular Ca2+ increase; consequently, mitochondria as the cellular
Ca2+ buffer become the primary effecter; meanwhile, mitochondrial NOS and
Ca2+-dependent proteases are also closely linked to this cellular response,
leading to possible mitochondrial ROS production and cytoskeletal degradation.
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Overall, these processes play significant contributory role in the delayed cell
death. However, the interwoven relationship of these processes makes it difficult
for therapeutic intervention, and pharmacological interpretation flawed without
timely assessments.
The central hypothesis underlying the present study is that an initial
trauma-induced Ca2+ overload, caused by glutamate and depolarization
evoked Ca2+ entry, elicits the mitochondrial generation of the ROS species
PN. PN-derived radical species result in oxidative damage to the
mitochondria and other cellular elements leading to an exacerbation of
intracellular Ca2+ accumulation. This in turn exacerbates calpain activity
which mediates cytoskeletal degradation and neurodegeneration. If this
scenario is correct, compounds that can penetrate cellular mitochondria
and antagonize PN-induced oxidative damage (e.g. PN-derived free radicals
scavenger, tempol) should be neuroprotective in that the resulting
antioxidant effect will lessen calcium overload, calpain activity and
associated cytoskeletal degradation and neurodegeneration as shown in
Figure 1.4. This dissertation study began with a thorough assessment of the time
course of PN-induced lipid peroxidation and protein nitration, calpain-mediated αspectrin breakdown and neurodegeneration with the de Olmos aminocupric silver
staining method as reported in Chapter 2. Secondly, a detailed pharmacological
study was conducted using antioxidant, tempol, to determine its ability to inhibit
post-traumatic

oxidative

damage.

Thereafter,

the

effect

of

tempol

on

mitochondrial ROS production and mitochondrial function, as well as calpain
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activity was tested. These experiments are described in Chapter 3. Finally, the
ability of tempol to improve neurological outcome and lessen post-traumatic
neurodegeneration is discussed in Chapter 4. Taken together, these studies
provide evidence for a post-traumatic pathological scenario that involves a critical
early role of PN and suggests that interruption of PN-mediated oxidative damage
is a valid therapeutic strategy. Copyright © Ying Deng 2007.

Figure 1.4 Hypothetical interrelationship between mitochondrial PN-induced
oxidative damage in neuronal mitochondria and the rest of the neuron,
compromise

of

Ca2+

homeostasis,

neurodegeneration.
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calpain-mediated

proteolysis

and

Chapter Two
Temporal Relationship of Peroxynitrite-Induced Oxidative Damage,
Calpain-Mediated Cytoskeletal Degradation and Neurodegeneration after
Traumatic Brain Injury

Introduction

There is compelling evidence supporting the role of oxidative damage in
the delayed secondary neuronal cell death which is initiated by the primary
traumatic brain injury (TBI). The first work in this regard, conducted by Kontos
and his colleagues, demonstrated the formation of

superoxide radicals in

cerebral microvasculature in a cat fluid percussion TBI models (Kontos and
Povlishock 1986; Kontos and Wei 1986). Using the salicylate trapping method,
Hall and coworkers detected a rapid, but transient rise in brain hydroxyl radical
(•OH) in experimental head injury models (Hall, Andrus et al. 1993; Hall, Andrus
et al. 1994; Smith, Andrus et al. 1994). This was elegantly confirmed by others
using brain microdialysis techniques to monitor salicylate-trapped •OH over time
in the same animals (Globus, Alonso et al. 1995). The increase of •OH is
followed by an increase in lipid peroxidation products (Smith, Andrus et al. 1994).
The strongest support for a role of oxidative damage in the acute
pathophysiology of TBI is derived from the fact that several antioxidant
compounds have been shown to be neuroprotective in TBI models (Hall, Andrus
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et al. 1994; Awasthi, Church et al. 1997; Mori, Kawamata et al. 1998; Marklund,
Lewander et al. 2001).
The reactive oxygen species (ROS) peroxynitrite (PN), which can produce
highly reactive and cytotoxic free radicals, has been suggested to be a key player
in post-traumatic secondary brain oxidative damage (Hall, Kupina et al. 1999;
Hall, Detloff et al. 2004). Peroxynitrite is formed by the chemical reaction of nitric
oxide (NO•), produced by nitric oxide synthase (NOS), with superoxide radical
(O2• ⎯) whenever the two are produced in close proximity (Saran, Michel et al.
1990). All three NOS isoforms (eNOS, iNOS, and nNOS), as a key element in
production of PN, have been shown to be up-regulated in brain tissue following
TBI (Cobbs, Fenoy et al. 1997; Wada, Chatzipanteli et al. 1998; Gahm, Holmin et
al. 2000; Orihara, Ikematsu et al. 2001). In addition, a novel isoform of Ca2+sensitive NOS (mtNOS), discovered within mitochondria (Bates, Loesch et al.
1995; Lopez-Figueroa, Caamano et al. 2000; Giulivi 2003), has been shown to
contribute to mitochondrial production of NO• and PN (Radi, Cassina et al. 2002).
The PN-derived free radicals (•NO2, •OH, •CO3⎯) can induce extensive oxidative
damage to cellular membranes, proteins and DNA (Beckman 1996; Murphy,
Packer et al. 1998; Radi 1998). Each of the PN-derived free radicals can initiate
lipid peroxidation (LP), or cause protein carbonylation by reaction with
susceptible amino acids (e.g. lysine, cysteine, arginine). Moreover, aldehydic LP
products (e.g. 4-hydroxynonenal) can bind to cellular proteins compromising their
structural and functional integrity (Neely, Sidell et al. 1999). Additionally, •NO2
can nitrate 3 position of tyrosine residues in proteins. As a result, 3-nitrotyrosine
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(3NT) is used as a specific footprint of PN-induced cellular damage (Hall,
Oostveen et al. 1997).
In recent work we investigated the role of PN in a mouse model of diffuse
closed head injury which demonstrated the spatial and temporal coincidence of
PN-induced protein nitration and lipid peroxidation and that this oxidative damage
precedes,

and

therefore

may

have

a

causal

role

in

post-traumatic

neurodegeneration (Hall, Detloff et al. 2004). However, TBI is a complex disorder
that is impossible to fully reproduce in a single model. For example, we have
found significant differences between the time courses of neurodegeneration in
mouse models of diffuse (Kupina, Detloff et al. 2003) and focal (Hall, Gibson et
al. 2005; Hall, Sullivan et al. 2005) TBI. Hence, the magnitude and timing of posttraumatic secondary injury mechanisms probably varies across head injury
models. Most importantly, if we are to accurately test the efficacy of novel
neuroprotective pharmacological treatments, it is important to first understand the
time course of the relevant secondary injury mechanisms in models of focal as
well as diffuse TBI.
Thus, the present study was conducted to examine the temporal and
spatial characteristics of PN-induced cortical oxidative damage in a model of
severe controlled cortical impact (CCI) focal TBI, and its relationship to calpainmediated cytoskeletal degradation and neurodegeneration. Markers for PNinduced protein nitration (3-nitrotyrosine, 3NT), and lipid peroxidation (4hydroxynonenal, 4HNE) were measured using immuno-slotblotting and immunohistochemistry. Secondly, we employed western-blotting methods to look at the
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time course of calpain-mediated cytoskeletal degradation in order to assess the
temporal relationship of oxidative damage to Ca2+-mediated proteolytic
degradation. Finally, we used de Olmos silver staining to measure the evolution
of post-traumatic neurodegeneration. The results demonstrate that the PNmediated oxidative damage is an early event that probably contributes to an
exacerbation of neuronal intracellular Ca2+ overload, massive calpain activation
and cytoskeletal degradation and neurodegeneration.
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Materials and Methods

All the surgical, injury and animal care protocols described below have
been approved by the University of Kentucky Institutional Animal Care and Use
Committee, and are consistent with the animal care procedures set forth in the
guidelines of the U.S. Public Health Service Policy on Humane Care and Use of
Laboratory Animals.

Mouse Model of Controlled Cortical Impact (Focal) Traumatic Brain Injury
Young adult male CF-1 mice (Charles River, Portage, MI) weighing 2931g were used in this study. The mice were anesthetized with isoflurane (3.0%),
shaved, and then placed in a stereotaxic frame (David Kopf Instruments,
Tujunga, CA). Throughout the surgery, the mice were provided with constant
isoflurane (SurgiVet, 100 Series) and oxygen (SurgiVet, O2 flowmeter, 0-4Lpm).
The head was positioned in the horizontal plane of a stereotaxic frame with the
nose bar set at zero. We firstly produced a 4mm craniotomy lateral to the sagittal
suture, and centered between lambda and bregma. A cortical contusion was
produced on the exposed cortex (the anterior-posterior coordinate for the
epicenter of the injury was Bregma -2.0mm) using a pneumatically-controlled
impactor device (Precision System Instruments TBI-0200 Impactor, Lexington,
KY) similar to that previously described (Sullivan, Bruce-Keller et al. 1999;
Sullivan, Thompson et al. 1999; Hall, Sullivan et al. 2005) except that the current
device utilizes a unique contact sensor mechanism that ensures accurate and
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reliable determination of cortical surface prior to initiating the injury sequence.
This results in increased accuracy and reproducibility in regards to the CCI injury
compared to that produced by earlier CCI impactors. In the present studies, the
impactor containing a 3mm diameter rod tip compressed the cortex at 3.5m/sec
to a depth of 1mm with a dwell time of 50msec to produce a severe injury. After
surgery and injury, a 4mm disk made from dental cement (Dentsply Trubyte) was
placed over the craniotomy site and adhered to the skull using cyanoacrylate. In
order to prevent immediate post-traumatic hypothermia, following the suturing of
the skin, mice were placed in a Hova-Bator incubator (37˚C, model 1583, Randall
Burkey Co) until them regained consciousness (determined by the regain of the
righting reflex and increased mobility). The injured mice were allowed to survive
from 30 min to 7 days depending on their experimental group. For the
neurochemical studies (measurement of oxidative damage markers and
cytoskeletal degradation, see below), the N for each time point group was 8
animals based upon our experience with the variability seen with these
measurements in previous studies (Kupina, Detloff et al. 2003; Hall, Detloff et al.
2004; Hall, Sullivan et al. 2005). For each time point, two sham animals were
included which were mice that received craniotomy but not cortical contusion.
The two sham animals in each group were killed at each of the post-traumatic
times along with their brain-injured counterparts. Eight sham mice were randomly
selected for comparison with the injured groups.
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Tissue Extraction and Protein Assay
At the selected times for the time course analysis (30 min, 1 hr, 3 hrs, 6
hrs, 12 hrs, 24 hrs, 48 hrs, 72 hrs and 7 days), the sham or CCI-injured mice
were deeply overdosed with sodium pentobarbital (200mg/kg i.p.). Following
decapitation, the ipsilateral cortex were rapidly dissected on an ice-chilled stage
and immediately transferred into pre-cooled Triton lysis buffer (1% triton, 20mM
tris HCL, 150mM NaCl, 5mM EGTA, 10mM EDTA, 10% glycerol) with protease
inhibitors (Complete MiniTM Protease Inhibitor Cocktail tablet). Samples were
then briefly sonicated and vortexed at 14,000rpm for 30 min at 4°C, and the
supernatants were collected for protein assay. Protein concentration was
determined by Bio-Rad DC Protein Assay, with sample solutions diluted to
contain 1mg/ml of protein for immunoblotting.

Slot-Immunoblotting Analysis of Oxidative Damage (3NT and 4HNE)
To measure 3-nitrotyrosine (3NT) or 4-hydroxynonenal (4HNE), an aliquot
of each ipsilateral cortical sample (2µg) was diluted with 200µl of tris-buffered
saline (TBS), and transferred to a Protran (0.2µm) nitrocellulose membrane
(Schleicher & Schuell, Dassel, Germany) by a Minifold II vacuum slot blot
apparatus (Schleicher & Schuell). After the samples were loaded into the slots,
they were allowed to filter through the membrane by gravity (no vacuum). Each
slot was then washed with 200µl TBS which was allowed to filter through the
membrane again. The membranes were then disassembled from the apparatus,
and incubated in a TBS blocking solution with 5% milk for 1 hr at room
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temperature. For the detection of 3NT, a rabbit polyclonal anti-nitrotyrosine
antibody (Upstate Biotechnology, MA, USA) was used at a dilution of 1:2000 in
TBST blocking solution with 5% milk for overnight at 4°C. For the detection of
HNE, a rabbit polyclonal anti-HNE antibody (Alpha Diagnostics International) was
used at a dilution of 1:5000 in TBST blocking solution with 5% milk for overnight
at 4°C. A goat anti-rabbit secondary antibody conjugated to an infrared dye
(1:5000, IRDye800CW, Rockland) was applied to the membrane for 1 hr at room
temperature. Dry membranes were then imaged and quantified using the Li-Cor
Odyssey

Infrared

Imaging

System

(Li-Cor®

Biosciences).

Preliminary

experiments established protein concentration curves in order to ensure that
quantified blots were in the linear range. From the results of these, we selected
the 2µg for use based upon that amount giving blots that were well within the
linear range. A standardized protein loading control was included on each blot to
normalize the band densities so that comparisons could be made across multiple
blots. All the samples were run in duplicate which were then averaged. For both
the 4HNE and 3NT analyses, no primary antibody controls were run to verify that
the oxidative damage staining was specific. In addition, we ran positive controls
using both bovine serum albumin and normal brain tissue which were exposed to
PN and negative controls in which we pre-absorbed the primary antibodies with
either 4HNE or 3NT which resulted in inhibition of the 4HNE and 3NT staining.
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Immunohistochemical Analysis of Oxidative Damage (3NT and 4HNE)
A second set of animals was employed for immunohistochemical analysis
of 3NT and 4HNE. At the appointed times for the post-traumatic time course
analysis (30 min, 1 hr, 3 hrs, 6 hrs, 12 hrs), groups of 5 mice each were
overdosed with sodium pentobarbital (200mg/kg i.p.). Two sham, non-injured
mice that had craniotomies, but no injury, were included for each time point. The
mice were then perfused transcardially with 0.9% sodium chloride (pH7.4) until
the venous effluent (sectioned superior vena cava) was cleared of blood,
followed by a fixative solution made with 4% paraformaldehyde in 0.2M PBS
(pH7.4). The heads were decapitated after fixation and stored in the same
fixative solution overnight at 4°C. The brains were removed and equilibrated in
the same fixative solution with 15% sucrose overnight at 4°C. The equilibrated
brains were sectioned at a thickness of 35µm into the same fixative solution with
15% sucrose at -20°C using a microtome with a freezing stage.
For the 4HNE detection, the free-floating sections were pre-treated with
0.1M NaBH4 in 0.1M MOPS (pH8.0) for 10 min and rinsed off with 0.2M PBS for
three times. The sections were then incubated in 0.3% H2O2 for 30 min and
rinsed three times with 0.2M phosphate-buffered saline (PBS). Following that, the
sections were blocked with a blocking solution (5% goat serum, 0.25% Triton X100, 1% dry milk, 0.2M PBS) for 2 hrs at room temperature, and then incubated
in the primary anti-HNE antibody (rabbit anti-HNE Michael Adducts, Calbiochem)
diluted 1:5500 in the same blocking solution overnight at room temperature. The
sections were then rinsed with 0.2M PBS six times, and then incubated in
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secondary goat anti-rabbit antibody (Vectastain ABC-AP kit) for 2 hrs at room
temperature. The sections were then rinsed with 0.1M Tris-HCl (pH8.2) and
incubated in Vector blue (Vector blue alkaline phosphatase substrate kit III). They
were then rinsed with tap water four times, and mounted onto gelatinized slides.
For the 3NT detection, the sections were not pre-treated with 0.1M NaBH4 in
0.1M MOPS (pH8.0), but were treated the same for the rest of the procedure,
except that they were incubated in the primary anti-3NT antibody (rabbit antinitrotyrosine, Upstate) diluted 1:1200 in the blocking solution. For both the 4HNE
and 3NT analyses, control slides were run without the primary antibodies to verify
that the oxidative damage staining was specific. In addition, we ran additional
controls in which we pre-absorbed the primary antibodies with either 4HNE or
3NT which resulted in inhibition of the 4HNE and 3NT immunostaining. After the
immunohistochemical procedure, all slides mounted with brain sections were
counterstained with nuclear fast red (Vector Lot# Q1214), and then cover
slipped. The brain sections were photographed on an Olympus Provis A70
microscope at 1.25x, 20× and 40× magnification using an Olympus Magnafire
digital camera.

Western-blotting Analysis of Calpain-mediated Cytoskeletal Degradation
To measure calpain-mediated α-spectrin proteolysis, aliquots of each
cortical sample (5µg) were run on a SDS/PAGE Precast gel (3-8% Tris-Acetate
CriterionTM XT Precast gel, Bio-Rad) and then transferred to a nitrocellulose
membrane using a semi-dry electro-transferring unit set at 15V for 15 min.
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Preliminary experiments established protein concentration curves in order to
ensure that quantified bands were in the linear range as measured with the LiCor Odyssey Infrared Imaging System. The membranes were incubated in a
TBS blocking solution with 5% milk for 1 hr at room temperature. For the
detection of α-spectrin and its breakdown products, a mouse monoclonal anti-αspectrin antibody (Affiniti FG6090) was used at a dilution of 1:5000 in TBST
blocking solution with 5% milk for overnight at 4°C. A goat anti-mouse secondary
conjugated to an infrared dye (1:5000, IRDye800CW, Rockland) was then
applied for 1 hr at room temperature. After drying, the membranes were then
imaged and quantified using the Li-Cor Odyssey Infrared Imaging System. A
standardized protein loading control was included on each blot to normalize the
band densities so that comparisons could be made across multiple blots (Hall,
Sullivan et al. 2005). This was made up of pooled brain tissue protein collected
from previously run TBI mice which gave strong bands corresponding to the
280kD parent α-spectrin, the 150kD and the 145kD breakdown products. The
amount of protein in the loading control had been previously determined and
shown to be within the linear range as measured with the Li-Cor Odyssey
Infrared Imaging System.

Following the transfer, the gels were stained with

Coomassie Blue to verify even transfer. All the samples were run in duplicate and
averaged.
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De Olmos Silver Staining Analysis of Neurodegeneration
Neurodegeneration was examined using the de Olmos aminocupric silver
histochemical technique in a third set of 27 mice as previously described (de
Olmos, Beltramino et al. 1994; Switzer 2000; Hall, Gibson et al. 2005; Hall,
Sullivan et al. 2005). At either 6, 12, 24, 48, or 72 hrs or 7 days the injured mice
(N=3-4 per time point) were overdosed with sodium pentobarbital (200mg/kg i.p)
and transcardially perfused with 0.9% sodium chloride, followed by a fixative
solution containing 4% paraformaldehyde; a sham group of 4 mice that received
craniotomy only were sacrificed 24 hrs following surgery. Following decapitation,
the heads were stored in a fixative solution containing 15% sucrose for 24 hrs
after which the brains were removed, placed in fresh fixative and shipped for
histological processing to Neuroscience Associates Inc (Knoxville TN). The 27
brains used for this study were embedded into one gelatin block (Multiblock®
Technology, Neuroscience Associates). The block was then frozen and thirteen
35µm coronal sections were taken 420µm apart between 1.1mm anterior and
4.4mm posterior to bregma, were de Olmos silver-stained to reveal degenerating
neurons and neuronal processes, and then counterstained with Nuclear Fast
Red. The brain sections were photographed on an Olympus Provis A70
microscope at 1.25× magnification using an Olympus Magnafire digital camera
and the image was analyzed by Image-Pro Plus (4.0). The percentage area of
silver staining for each brain section was calculated by dividing the area of silver
staining in each section by the area of the total hemispheric section and
multiplying by 100. The volume of silver staining in the hemisphere as a
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percentage of the overall hemispheric volume was estimated by the equation %
V = t × Σ % a(s), where % V is percent silver stain volume, t = the distance
between sections analyzed (420µm) and Σ % a (s) is the sum of percent area of
silver staining in all sections examined (13 for each brain) (Hall, Sullivan et al.
2005).

Statistical Analysis
For all of the time course analyses, we used Statview 5.0 to perform a
one-way analysis of variance (ANOVA), followed by Fisher’s PLSD post-hoc
analysis to determine the significance of differences between individual time
points and the non-injured sham group. For the ANOVA, a p<0.05 was required
to establish a statistically significant difference across the groups. However, for
the post-hoc Fisher’s analysis, the program determined significance based upon
a correction for multiple comparisons comparing sham to each of the 9 postinjury time points. Differences between pairs of post-injury time points (e.g. 30
min. vs. 1 hr) were also analyzed.
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Results

Quantitative Post-Traumatic Time Course of Protein Nitration and Lipid
Peroxidation
Figure 2.1 displays the complete quantitative time course study for 3NT
and 4HNE in the ipsilateral cortical samples taken from sham or CCI-injured
mice. Figure 2.1A indicates schematically the dorsal and coronal view of
contusion site and peri-contusional cortical tissue that was collectively sampled
for the current study. Figure 2.1B shows the time course of changes in 3NT, a
selective marker of PN-mediated damage. As noted in the MATERIALS AND
METHODS, two non-injured sham animals corresponding to each post-traumatic
time point were run. For the nine time points, this resulted in a total of 18 shams.
A comparison of the bands obtained from different pairs of shams, showed little
evidence that those animals killed at the later time points had any more 3NT or
4HNE than those sampled at the earlier time points. Therefore, we randomly
selected 8 of the 18 shams to use as the sham group for comparison with the
different injured groups. The ANOVA showed that there was a highly significant
overall difference across the collective sham and post-traumatic groups in
regards to 3NT levels [F(9,70)=2.744; p<0.0001]. Post-hoc analysis revealed a
significant increase in 3NT at 30 min after injury compared to the sham group. At
1 hr after injury, the 3NT level reached its peak and was approximately twice as
much as that seen in sham, non-injured mice. The 3NT level maintained
significantly high until 12 hrs after injury, and at 24 hrs, it returned to baseline
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(sham level). However, a small, but statistically significant secondary increase in
3NT was also observed at 48, but not at 72 hrs.
Figure 2.1C displays the time course of post-traumatic changes in 4HNE,
a marker for lipid peroxidation, at different time points after injury. As with the
3NT analysis, there was a highly significant overall difference across the
collective sham and post-traumatic groups in regards to 4HNE content
[F(9,70)=15.211; p<0.0001]. Post-hoc analysis of between group differences
showed that there was a significant increase in 4HNE at 30 min after injury, the
4HNE level reached its peak at 1 hr after injury and it stayed significantly higher
than the sham level until 12hr before returning to the baseline levels seen in the
sham animals.
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Figure 2.1 Slot-blotting studies in ipsilateral cortical traumatic brain injury tissues
showing the temporal changes in protein nitration (3-nitrotyrosine; 3NT) and lipid
peroxidation. A. Schematic showing peri-contusional cortical tissue samples; B.
time course of changes in 3-NT; C. Time course of LP end product 4HNE. N = 8
animals per timepoint; values = mean + standard error; one-way ANOVA and
Fisher’s PLSD post hoc test: *P < 0.0001 vs. sham.
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Spatial and Temporal Distribution of Peroxynitrite-Induced Protein Nitration and
Lipid Peroxidation
Figure 2.2 demonstrates the temporal and spatial characteristics of the
immunohistochemical staining related to post-traumatic oxidative damage in the
ipsilateral hemisphere of mice after CCI injury. Two adjacent brain sections in the
epicenter (Bregma-2.0mm) of the contusion were selected for 3NT staining and
4HNE staining. In Figure 2.2, the staining for 3NT and 4HNE markers were
concentrated within and around the contusion area in the ipsilateral cortex, and
the 3NT and 4HNE staining was largely overlapping. Staining for both markers
was observed as early as 30 min. Staining remained intense up to 6 hrs after
injury. At 12 hrs, the staining showed signs of decrease no doubt due to
proteolytic degradation of the oxidatively modified proteins. This time course is in
good agreement with the quantitative time course for 3NT and 4HNE shown in
Figure 2.1.
Figure 2.3 shows high power photomicrographs of 3NT and 4HNE
immunostaining within the cortical contusion site in a sham, non-injured brain
compared to staining at the contusion site at 1 hr after injury. At 20x and 40x
magnification, intense staining for both oxidative damage markers is seen
throughout the neuropil. In addition, microvascular staining for both 3NT and
4HNE is seen to clearly outline the microvessels deep within the injured cortex.
Although the sham brain shows some light staining in the neuropil, there is no
evidence of staining of non-injured microvessels. The pattern of staining in both
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the parenchyma and vasculature has also been seen previously after a diffuse
brain injury (Hall, Detloff et al. 2004).

Figure 2.2 Immunohistochemical (IHC) staining studies showing the time course
and spatial extent of PN-induced 3NT and 4HNE at the epicenter (Bregma2.0mm) of the injury site during the first 12 hrs compared to sham. The IHC
staining indicated prominent increase of both markers after injury and similar
distribution between the two.
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Figure 2.3 High power photomicrographs of 3NT and 4HNE immunostaining in
the contusion site in a sham, non-injured brain compared to staining at the
contusion site at 1 hr after injury. At 20x and 40x magnification, intense staining
for both oxidative damage markers is seen throughout the neuropil. In addition,
microvascular staining for both 3NT and 4HNE is seen to clearly outline the
microvessels (arrows) deep within the injured cortex. Although the sham brain
shows some light staining in the neuropil, there is no evidence of staining of noninjured microvessels. Please note that the 20x and 40x focus was adjusted to
emphasize the microvascular staining, and as a result the background tissue
appears slightly out of focus. The calibration bar for the 1.25x photomicrographs
is 2.0mm; for 20x the calibration bar is 100µm; for 40x the calibration bar is
50µm.

50

Quantitative Post-traumatic Time Course of Calpain-Mediated Cytoskeletal
Degradation
Figure 2.4 displays the quantitative post-traumatic time course analysis of
calpain-mediated cytoskeletal degradation in the ipsilateral cortical tissue in
terms of the levels of α-spectrin breakdown products SBDP145 and 150
measured by western-blotting. The spectrin breakdown product 145 (kD) and 150
(kD) in each time group were compared to the sham SBDP145 and the sham
SBDP150 respectively. The SBDP150 band can be produced by either calpain or
caspase 3, whereas the SBDP145 band is calpain specific. ANOVA showed that
there

was

a

[F(9,70)=9.444;

significant
p<0.0001]

overall
and

post-traumatic
SBDP150

increase

in

[F(9,70)=8.857;

SBDP145
p<0.0001].

Accordingly, post-hoc analysis of the significance of increases seen at individual
post-traumatic time points was compared to sham, non-injured animals. At 30
min after injury, the mean SBDP150 level was significantly increased. The levels
of this mixed calpain/caspase 3 marker remained significantly higher than sham
levels at all subsequent time points out to, and including, 48 hrs post-injury. The
maximum increase in SBDP150 was observed at 24 hrs post-injury. The calpainspecific SBDP145 showed a significant increase vs. sham beginning at 1 hr postinjury, and increased slightly more at 3, 6 and 12 hrs.
Between 12 and 24hrs, there was a statistically significant (12 hr vs. 24 hr;
p<0.0004) 75% jump in SBDP145 levels with the 24 hrs time point manifesting
the maximum post-traumatic increase. In parallel, there was an equally
significant (12 vs. 24 hr; p<0.0001) increase in the SBDP150 levels SBDP150.
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The magnitude of the increase in SBDP145 was greater (compared to the sham
group) (18-fold) in comparison to the SBDP150 increase (6-fold). The level of
SBDP145 remained significantly elevated at 48 hrs before returning to levels at
72 hrs after TBI that were no longer significantly higher than those seen in sham
animals. The overall time course patterns were similar for both SBDP150 and
SBDP145.
It should be noted that the current post-traumatic time course of α-spectrin
degradation, although similar in several respects to a time course study we
published earlier (Hall, Sullivan et al. 2005) using the CCI model, shows some
differences that are worthy of explanation. In the previous study, the earliest
post-traumatic time point examined was 6 hrs at which time we observed a
statistically significant increase in SBDP145 and 150 compared to sham, just as
in the present study. However, the elevation in SBDPs did not increase further at
24 or 48 hrs, but rather appeared to plateau before returning to the sham
baseline level at 1 week. This is in contrast to the significantly higher peak in
SBDP 145 and 150 observed in the current study. There are two likely reasons
for the discrepancy between the current and the previously published time course
(Hall, Sullivan et al. 2005). First of all, in the current study we employed a more
sensitive infrared imaging method for performing the densitometric analysis of
the blots which has a broader linear range compared to the less sensitive
enhanced chemiluminescence (ECL) method that we previously employed which
is only semi-quantitative. Consequently, the previous plateau between 6 and 72
hrs post-injury (Hall, Sullivan et al. 2005), in contrast to the current results is
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probably due to the less accurate nature of ECL vs. infrared imaging. Secondly,
the current study was performed with a newer CCI device than the one used in
the previous study. The newer device (PSI TBI 0200 Impactor) utilizes a unique
contact sensor mechanism that insures accurate and reliable determination of
cortical surface prior to initiating the injury sequence. This results in increased
accuracy and reproducibility in regards to the CCI injury. Thus, for these two
reasons, we have more confidence in the accuracy of the current results in
regards to the time course of post-traumatic cytoskeletal degradation.
Furthermore, the current time course of α-spectrin degradation in the CCI-injured
cortex is similar in pattern to the time course of α-spectrin degradation we have
seen in the injured hippocampus using the same injury device, injury severity and
infrared imaging of the blots (Thompson, Gibson et al. 2006)
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Figure 2.4 Time course of the post-traumatic increase in calpain-mediated αspectrin breakdown products in CCI cortical tissues. Spectrin breakdown product
(SBDP) 145 is specific to calpain activity, whereas SBDP 150 is produced by
both calpain and caspase 3. Both SBDPs showed similar patterns, except that
calpain-mediated SBDP 145 showed a more prominent increase. Both SBDPs
have an immediate increase following injury, and did not reach their peak until 24
hrs. N = 8 animals per timepoint; values = mean + standard error; one-way
ANOVA and Fisher’s PLSD post hoc test: *P < 0.0001 vs. sham SBDP150; oneway ANOVA and Fisher’s PLSD post hoc test: #P < 0.0001 vs. sham SBDP145.
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Quantitative Post-Traumatic Time Course of Neurodegeneration
Figure 2.5 shows the quantitative de Olmos aminocupric silver staining
analysis of neurodegeneration in the ipsilateral hemisphere of mice subjected to
CCI along with histological examples of the spatial and temporal characteristics
of silver staining between 6 hrs and 7 days after injury. At 6 hrs after injury, there
was a significant increase of silver staining volume compared to minimal level
seen in sham, non-injured mouse brains. The silver staining spread over time
and peaked at 48 hrs after injury. After 48 hrs, the volume of silver staining slowly
waned, but remained significantly higher than the sham level even at 7 days. As
shown in the selected brain sections, at 6 hrs, the silver staining was mainly
concentrated in all layers in the ipsilateral cortical contusion. A cavitation lesion
began to develop at 12 hrs and became evident at 24 hrs. At 24 hrs, the silver
staining had spread into and throughout the ipsilateral hippocampus and
dorsolateral aspect of the thalamus. At 48 hrs, the silver staining volume reached
its greatest extent. Silver staining also extended to the contralateral
hippocampus, indicative of the degeneration of CA3 commissural fiber
projections to the contralateral dentate gyrus and CA1 region as previously
shown (Hall, Sullivan et al. 2005).
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Figure 2.5 Time course of post-traumatic neurodegeneration in CCI model as
revealed by the de Olmos silver staining technique. The bar chart provides the
quantification of the lesion volume abut measurement of the silver staining. An
increase in silver staining volume determined by image analysis (see Materials
and Methods) occurred as early as 6 hrs and reached its peak at 48 hrs postinjury. N = 3-4 animals per time point; values = mean + standard error; one-way
ANOVA and Fisher’s PLSD post hoc test: *P < 0.0001 vs. sham.
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Discussion

The present study in the context of the focal controlled cortical impact
(CCI) mouse model has uniquely defined in a parallel fashion the time courses of
oxidative

damage,

calpain-mediated

cytoskeletal

degradation

and

neurodegeneration. A careful analysis of these three secondary injury
parameters has revealed clues concerning their mechanistic inter-relationships.
The following discussion lays out the hypothesis that 1) the potent ROS PN is a
key mediator of post-traumatic oxidative damage; 2) a major source of PN is
Ca2+-overloaded mitochondria; 3) a major consequence of PN-mediated oxidative
damage is exacerbation of intracellular Ca2+ overload by impairment of Ca2+
homeostatic mechanisms and 4) this leads to an enhancement of calpainmediated cytoskeletal degradation which is the immediate precursor of posttraumatic neuronal degeneration.

Temporal and Spatial Characteristics of Oxidative Damage and the Role of
Peroxynitrite:
The two oxidative markers: tyrosine nitration (3NT) and LP-derived 4HNE
modified proteins (see Halliwell and Gutteridge, 1999), increased in unison. Their
increase occurred as early as 30 min after injury and peaked at 1hr. The
coincidence of the early time course of 3NT and 4HNE suggests that they share
a common ROS as their initiating source. The most likely candidate ROS in this
regard is PN. The nitration of the 3 position of tyrosine residues in proteins is a
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result of PN activity and is used as a selective marker for PN-induced oxidative
damage. Therefore, it is generally accepted as evidence of a role of PN in tissue
injury models where 3NT elevations are seen (Beckman 1996). Moreover, the
indictment of PN as a source of LP (4HNE) is strongly implied by the fact that
3NT and 4HNE share the same early post-traumatic onset (30 min), time to peak
(1 hr) and duration (12 hrs). Furthermore, spatial overlap of 3NT and 4HNE seen
in the immunohistochemical examples also indicates that nitration and LP are
both initiated by PN. Previous work from our laboratory using a mouse model of
diffuse TBI, has also shown the spatial and temporal coincidence of 3NT and
4HNE immunostaining leading to a similar conclusion that PN was key player in
the post-traumatic oxidative damage (Hall, Detloff et al. 2004). However, in the
case of the previously studied diffuse TBI model, the duration of the increase in
3NT and 4HNE was much longer (at least 96 hrs) in contrast to the much shorter
expression of oxidative damage in the presently employed focal paradigm.
Particularly important is the fact that PN-mediated oxidative damage was
observed in both the cortical microvessels and in the neural parenchyma
consistent with our earlier studies in the mouse diffuse TBI model (Hall, Kupina et
al. 1999; Hall, Detloff et al. 2004)

Sources of Peroxynitrite:
Regarding the sources of PN in the injured brain, NO• is produced by
multiple NOS isoforms, and is a mediator of physiological (Garthwaite and
Boulton 1995; Bicker 2001) and neuroprotective (Mohanakumar, Hanbauer et al.
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1998; Chiueh 1999) actions as well as being an effecter of PN formation and
oxidative damage (Dawson and Dawson 1996; Vicente, Perez-Rodriguez et al.
2006). An earlier immunocytochemical study revealed the induction of endothelial
NOS (eNOS) isoform in microvessels surrounding the cortical contusion postinjury, which may contribute to blood-brain barrier (BBB) breakdown and
hyperemia followed by TBI (Cobbs, Fenoy et al. 1997). Other isoforms of NOS,
neuronal NOS (nNOS) and inducible NOS (iNOS), have also been shown to be
upregulated in TBI models. In a focal brain contusion model, all three isoforms of
NOS (nNOS, eNOS, iNOS) have been found to be increased. However, each is
expressed in different compartments and cells, and is differentially regulated
(Gahm, Holmin et al. 2000). In addition, a possibly novel isoform of NOS
(mtNOS) is constitutively present in mitochondria, is Ca2+-dependent (Giulivi
2003) and appears to be involved in mitochondrial respiratory regulation
(Elfering, Sarkela et al. 2002).

Under hypoxic conditions, mtNOS activity is

induced in comparison to that seen in non-stressed mitochondria (Lacza, Puskar
et al. 2001). In rat liver mitochondria, mtNOS has been shown to stimulated by
Ca2+ influx (Ghafourifar and Richter 1997) and leads to intramitochondrial PN
formation (Ghafourifar, Schenk et al. 1999). Furthermore, there is evidence that
mitochondria may be the primary target for oxidative damage by PN under a
variety of pathological conditions (Radi, Rodriguez et al. 1994). Consistent with
this view, recent experiments from our laboratory, using the same mouse CCI
model as in the present study, have shown that the early post-traumatic
impairment of mitochondrial ultrastructure and bioenergetics are associated with

59

PN-mediated protein nitration and 4HNE conjugation together with a severe
attenuation of Ca2+ buffering capacity (Singh, Sullivan et al. 2006a). Furthermore,
our in vitro studies with isolated brain mitochondria have demonstrated that
application of compounds such as penicillamine, which scavenges PN anion
(ONOO•) and peroxynitrous acid (ONOOH) (Hall, Kupina et al. 1999), or tempol,
which catalytically scavenge PN-derived oxygen radicals (e.g. •NO2, •CO3)
(Carroll, Galatsis et al. 2000), can protect against PN-mediated mitochondrial
respiratory dysfunction and oxidative damage (Singh et al, 2006b). Both
penicillamine (Hall, Kupina et al. 1999) and tempol (Beit-Yannai, Zhang et al.
1996) have been reported to improve neurological recovery in rodent TBI
models. Moreover, administration of the NOS inhibitors nitro-arginine methyl
ester and 7-nitroindazole have been shown to improve neurological recovery in
head-injured mice (Mesenge, Verrecchia et al. 1996) together with a reduction in
brain 3NT levels (Mesenge, Charriaut-Marlangue et al. 1998).

Temporal Characteristics of Calpain-Mediated Cytoskeletal Damage:
Several experimental TBI studies from different laboratories have
documented the significant contribution of calpain activity to the post-traumatic
damage and neurodegeneration (Arrigoni and Cohadon 1991; Posmantur,
Kampfl et al. 1996; Saatman, Murai et al. 1996). Pathological calpain activation is
known to be triggered by excessive intracellular Ca2+ accumulation (Bartus, Elliott
et al. 1995; Kampfl, Posmantur et al. 1997), which is associated with the
glutamate release and sustained NMDA activation, as well as depolarization-
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induced opening of voltage-dependent Ca2+ channels immediately after CNS
trauma.

Preferred

substrates

for

calpain

include

cytoskeletal

proteins,

membrane-associated proteins, signaling transduction proteins and transcription
factors (Carafoli and Molinari 1998; Wang 2000). As noted earlier, calpainmediated proteolysis of the major membrane cytoskeletal protein, α-spectrin,
results in the appearance of two highly stable breakdown products, calpainspecific SBDP145 and the non-specific calpain/caspase 3-generated SBDP150.
Our results showed that there is a rapid accumulation of both SBDPs by 1 hr
after injury which further increases at 3 hrs before reaching a plateau at 6 and 12
hrs. Nevertheless, at 24 hrs, both SBDPs showed a significant increase above
the level seen at 12 hrs spiked to their peak with a particularly prominent
SBDP145 increase. Although a role of caspase 3 cannot be ruled out in regards
to the increase in SBDP150, the predominant elevation in the calpain-specific
SBDP145 at 24 hrs indicates that the major contribution of calpain to cytoskeletal
damage. In addition, the caspase 3 specific SBDP120 (Wang 2000) showed no
increase over time which suggests only a very minor role of caspase 3 in posttraumatic spectrin proteolysis. After 24 hrs, the SBDP 145 and 150 levels
progressively subsided, and both returned to the baseline level (sham) by 72 hrs
after injury.
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Interaction of Peroxynitrite-Induced Oxidative and Calpain-Mediated Proteolytic
Damage Mechanisms:
Multiple lines of evidence have linked ROS-initiated oxidative damage to
the loss of intracellular Ca2+ homeostasis and calpain activation. It has been
commonly indicated that ROS cause a rapid increase in cytoplasmic Ca2+
concentration in diverse cell types (Roveri, Coassin et al. 1992; Chakraborti, Das
et al. 1999; Okabe, Tsujimoto et al. 2000), which can contribute to the early
transient calpain activation. However, the current study indicated that the full
activity of calpain did not occur until a later time point that follows the early wave
of oxidative damage and the peak of mitochondrial dysfunction (Singh, Sullivan
et al. 2006a). At the point at which mitochondrial functional failure occurs, this
results in a loss of mitochondrial Ca2+ buffering and release of accumulated Ca2+
into the cytoplasm which would be expected to exacerbate calpain activation and
spectrin breakdown. It has been shown that mitochondria-derived PN plays a role
in mitochondrial Ca2+ overload, and can actually promote Ca2+ release from intact
mitochondria (Bringold, Ghafourifar et al. 2000). Moreover, we have previously
demonstrated that the mitochondrial failure is coincident with oxidative damage
to mitochondrial proteins and loss of mitochondrial Ca2+ buffering capacity
(Singh, Sullivan et al. 2006a). In an in vitro study, nitric oxide-elicited neuronal
apoptosis through excitotoxicity and receptor-mediated intracellular Ca2+
overload mechanisms was blocked by calpain inhibitors (Volbracht, Chua et al.
2005). Another in vitro study has also indicated that PN-initiated cell death in
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human articular chondrocytes is mediated by mitochondrial dysfunction and
calpain activity (Whiteman, Armstrong et al. 2004).
In addition to the apparent role of ROS in the post-traumatic impairment of
Ca2+ homeostasis, ROS also are involved in directly regulating calpain proteolytic
activity. As indicated in Figure 2.4, following an immediate and rapid increase of
SBDPs at 1 hr after injury, there is essentially a plateau in regards to the SBDP
levels between 3 hrs and 12 hrs. Then, between 12 hrs and 24 hrs, both SBDPs
exhibited a greater than 75% increase which was highly significant (p<0.0004 for
SBDP145 and p<0.0001 for SBDP150). A similar biphasic pattern of calpainmediated α-spectrin degradation has also been observed by our laboratory in the
context of a rat spinal cord injury model (Xiong, Rabchevsky et al. 2007) and by
others in a transient ischemic brain injury model (Neumar, Meng et al. 2001). In a
recent hippocampal organotypic slice study, stretch-induced injury also showed a
biphasic activation of calpain (DeRidder, Simon et al. 2006). This repeatedly
demonstrated biphasic time course of calpain-mediated proteolysis can
potentially be explained by an initial partial ROS-mediated inhibition of calpain
activity in the early post-traumatic hrs during which PN generation and evidence
of oxidative damage are at their highest level. Consistent with this hypothesis, it
has been shown that ROS can inhibit calpain activity via oxidation of the
sulfhydryl groups of cysteine residues at the active site of the enzyme (Benuck,
Banay-Schwartz et al. 1992; Guttmann, Elce et al. 1997; Guttmann and Johnson
1998). Recent work by another group has shown that another cysteine protease
caspase 3 in the traumatized brain is similarly inhibited by PN specifically, and

63

that this is prevented by application of the sulfhydryl reducing agent dithiothreitol
(Lau, Arundine et al. 2006).

The latter is also relevant since the SBDP150

fragment which also showed a biphasic time course is partially generated by
caspase 3 as well as calpain (Wang 2000). Therefore, it is reasonable to
speculate that even though intracellular Ca2+ overload is triggered immediately
after injury (Zhou, Xiang et al. 2001), the peak of calpain- and caspase-mediated
cytoskeletal degradation may not be achieved until as much as 24 hrs post-injury
after which an initial ROS-mediated calpain and caspase inhibition has subsided.
In other words, as the intensity of the PN generation decreases, the oxidative
damage-mediated impairment of various Ca2+ homeostatic mechanisms and the
neurodegenerative consequences of post-traumatic intracellular Ca2+ overload
and peak calpain activity would have the opportunity to be fully seen. This peak
in calpain-mediated damage at 24 hrs closely precedes the progressive increase
in post-traumatic neurodegeneration (silver staining) which peaks at 48 hrs.
We have observed the same close association between calpain-mediated
cytoskeletal degradation and neurodegeneration in the mouse diffuse TBI model
except that the peak of the former is seen at 72 hrs and that of the latter is seen
between 72 and 96 hrs (Hall, Detloff et al. 2004). The different time course of
PN-mediated oxidative damage and calpain-mediated cytoskeletal degradation
seen in focal and diffuse (Kupina, Detloff et al. 2003) TBI models suggests that
the therapeutic window and optimum treatment durations for either PN-directed
antioxidant agents or calpain inhibitor treatment may differ between the two types
of TBI.

64

Summary:
Our working hypothesis, based upon the findings in this study, is
illustrated in Figure 2.6. Initial mechanical trauma to the brain causes membrane
depolarization, resulting in the opening the voltage-dependent Na+, K+ and Ca2+
channels, and the release of glutamate into the extracellular spaces, which will
lead to the activation of NMDA receptors. Both mechanisms directly or indirectly
elevate intracellular Ca2+ and rapidly initiate the activation of intracellular
calpains. However, mitochondria take up the excessive Ca2+ in the cell, which
subsequently activates mitochondrial NOS and results in overproduction of NO•
radical. Elevated NO• out-competes superoxide dismutase (SOD) for superoxide
radical (O2• ⎯) leading to the formation of PN. Then, PN-derived free radicals
could be expected to initially produce a partial inhibition of calpain and caspase 3
activity. Mitochondria, however, as a major intracellular ROS source not only
become a primary location for PN production, but also are susceptible to PNinduced oxidative damage due to their enriched thiol and iron-rich structures
within the electron transport chain (ETC). In addition, the biochemical properties
of PN enable it to diffuse out of the mitochondria to induce further oxidative
damage to the cell membrane and cellular proteins. This increase in oxidative
stress during the first 12 hrs, induces cellular oxidative damage by LP, protein
oxidation and protein nitration. The calpain-mediated proteolysis displays a
biphasic activity probably as a result of an initial partial PN-mediated inhibition of
calpain. However, as this subsides, the extensive compromise of Ca2
homeostasis in the mitochondrion and the rest of the cell becomes manifest and
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calpain activity is free to reach its peak. In the end, calpain-mediated cytoskeletal
degradation becomes a final common pathway leading to neuronal cell death.
The findings of this study strongly support the concept of an important
pathophysiological role of PN-mediated oxidative damage following TBI.
Peroxynitrite-induced oxidative damage and calpain activation interact and are
probably responsible for much of the secondary injury and neurodegeneration
that occurs. If so, then PN-targeted antioxidants should be neuroprotective.
However, the combination of a PN-targeted antioxidant and a calpain inhibitor
might have a better neuroprotective action than either approach alone. Future
studies will explore these possibilities. Copyright © Ying Deng 2007.
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Figure 2.6 Hypothetical interrelationship between PN-induced oxidative damage
in neuronal mitochondria and the rest of the neuron, compromise of Ca2+
homeostasis, calpain-mediated proteolysis and neurodegeneration. Our results
suggest that PN-induced oxidative damage plays a key role in the post-traumatic
secondary injury, which leads to exacerbation of Ca2+ overload, calpain
proteolysis of cytoskeleton and other cellular proteins and neurodegeneration.
See Discussion for a further description.

67

Chapter Three
Tempol in Its Ability to Scavenge Free Radicals, Ameliorate Mitochondrial
Dysfunction and Inhibit Calpain Activity

Introduction
Nitroxide

antioxidants,

such

as

tempol

(4-hydroxy-2,2,6,6-

tetramethylpiperidine-1-oxyl, see Figure 3.1), are generally described in the
literature as potent metal-independent superoxide dismutase (SOD) mimics with
better membrane permeability and potency (Samuni, Krishna et al. 1989;
Krishna, Russo et al. 1996). Nitroxides have been shown to quench superoxide
radical (O2• ⎯) to eventually produce hydrogen peroxide and oxygen just like
SOD. Moreover, nitroxides prevent oxidative damage by removing superoxide
radical (O2• ⎯) catalytically rather than stoichiometrically. Moreover, six-membered
cyclic nitroxides such as tempol react faster as an antioxidant than corresponding
five-membered ring nitroxides (Samuni, Krishna et al. 1990). As often studied in
biological systems, nitroxides also have the ability to react with lipid peroxidation
(LP)-derived intermediates such as alkoxyl radical and peroxyl radical.
Furthermore, they can act as mild oxidizing agents to prevent the cycling of
transition medal irons (Fe2+ÆFe3+) and thereby inhibit the production of hydroxyl
radicals (•OH) via in Fenton-type reaction (Zeltcer, Berenshtein et al. 1997).
More recently, it has been shown that tempol can catalytically decompose
the peroxynitrite (PN) free radicals nitrogen dioxide (•NO2) and carbonate (•CO3).
High-performance liquid chromatography (HPLC) analysis measuring the
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intermediates of the reactions between tempol and PN-induced phenolic nitration
suggested that oxidized forms of tempol can exchange among themselves
without depletion in the reaction with PN-derived free radicals, which makes
tempol a potent catalytic antioxidant (Carroll, Galatsis et al. 2000).
Thus, because of its multiple antioxidant properties, and its membrane
permeability, tempol or similar compounds may have considerable therapeutic
values in protection against cytotoxicity that involves oxidative damage. In vivo
studies have indicated that tempol provides protection against X-ray-induced
DNA damage, or other radiation oncology (DeGraff, Krishna et al. 1992; Hahn,
Krishna et al. 1994). Tempol was also suggested to reduce PN-generated
nitration, decrease poly ADP-ribose synthetase (PARS) activation, as well as
reduce infarct volume and hyperactivity in ischemic experimental models
(Cuzzocrea, McDonald et al. 2000; Rak, Chao et al. 2000; Kato, Yanaka et al.
2003). Moreover, tempol was shown to reduce the pathophysiology of acute
subdural hematoma (ASDH) (Kwon, Chao et al. 2003). In a Parkinson’s disease
model, tempol was indicated to attenuate malonate and 1-methyl-4-phenyl1,2,5,6 tetrahydropyridine (MPTP)-induced neurotoxicity (Matthews, Klivenyi et
al. 1999). Furthermore, it has been shown that tempol can improve tissue sparing
and locomotor outcome after spinal cord injury (SCI) (Hillard, Peng et al. 2004).
Finally, tempol has been shown to limit edema formation, blood-brain barrier
(BBB) disruption and to improve functional recovery (Beit-Yannai, Zhang et al.
1996; Zhang, Shohami et al. 1998). In the latter studies, the mechanism of the
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neuroprotective antioxidant action was completely attributed by the authors to
superoxide scavenging.
The present study was undertaken in the controlled cortical impact (CCI)
mouse traumatic brain injury (TBI) model to examine the possibility that tempol’s
neuroprotective efficacy in acute TBI also involves inhibition of PN-mediated
oxidative damage in brain tissue, mitochondria and downstream amelioration of
calpain-mediated cytoskeletal breakdown. As demonstrated in our previous
study, the early increase of oxidative damage in mitochondrial proteins paralleled
to that in the cortical homogenate ipsilateral to the injury, which also coincided
with the time course of mitochondrial dysfunction following the injury (Chapter 2;
Singh, Sullivan et al. 2006a, see Appendix I and II). This strongly suggests the
idea that mitochondria are the primary source and target of PN upon
mitochondrial calcium uptake in the CCI model (Singh, Sullivan et al. 2006a).
Moreover, as also indicated in our time course study on cellular changes
triggered by TBI in the CCI model, the peak of oxidative damage at 1 hr after
injury

preceded

both

the

peak

of

calpain

activity

at

24

hrs

and

neurodegeneration, measured by silver staining, at 48 hrs (Deng, Thompson et
al. 2007). Therefore, the current experiments were conducted to investigate
tempol’s ability to reduce post-traumatic PN-induced oxidative damage,
mitochondrial dysfunction and calpain-mediated cytoskeletal degradation in order
to establish a mechanistic linkage between these successive pathophysiological
events.
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Figure 3.1 Chemical structure of tempol.
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Materials and Methods

All the surgical, injury and animal care protocols described below have
been approved by the University of Kentucky Institutional Animal Care and Use
Committee, and are consistent with the animal care procedures set forth in the
guidelines of the U.S. Public Health Service Policy on Humane Care and Use of
Laboratory Animals.

Mouse Model of Controlled Cortical Impact (Focal) Traumatic Brain Injury
Young adult male CF-1 mice (Charles River, Portage, MI) weighing 2931g were used in this study. The mice were anesthetized with isoflurane (3.0%),
shaved, and then placed in a stereotaxic frame (David Kopf Instruments,
Tujunga, CA). Throughout the surgery, the mice were provided with constant
isoflurane (SurgiVet, 100 Series) and oxygen (SurgiVet, O2 flowmeter, 0-4Lpm).
The head was positioned in the horizontal plane of a stereotaxic frame with the
nose bar set at zero. We firstly produced a 4mm craniotomy lateral to the sagittal
suture, and centered between lambda and bregma. A cortical contusion was
produced on the exposed cortex (the anterior-posterior coordinate for the
epicenter of the injury was Bregma -2.0mm) using a pneumatically-controlled
impactor device (Precision System Instruments TBI-0200 Impactor, Lexington,
KY) similar to that previously described (Sullivan, Bruce-Keller et al. 1999;
Sullivan, Thompson et al. 1999; Hall, Sullivan et al. 2005) except that the current
device utilizes a unique contact sensor mechanism that ensures accurate and
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reliable determination of cortical surface prior to initiating the injury sequence.
This results in increased accuracy and reproducibility in regards to the CCI injury
compared to that produced by earlier CCI impactors. In the present studies, the
impactor containing a 3mm diameter rod tip compressed the cortex at 3.5m/sec
to a depth of 1mm with a dwell time of 50msec to produce a severe injury. After
surgery and injury, a 4mm disk made from dental cement (Dentsply Trubyte) was
placed over the craniotomy site and adhered to the skull using cyanoacrylate. In
order to prevent immediate post-traumatic hypothermia, following the suturing of
the skin, mice were placed in a Hova-Bator incubator (37°C, model 1583, Randall
Burkey Co) until them regained consciousness (determined by the regain of the
righting reflex and increased mobility). The injured mice were allowed to survive
from 1 hr to 48 hrs depending on their experimental group. For the
immunoblotting studies (measurements of oxidative damage marker and
cytoskeletal degradation, see below), the N for each treatment group was 8
animals; whereas for the mitochondrial studies, the N for each treatment group
was 6 (3 mice were pooled together to create 1 N), based upon our experience
with the variability seen with these measurements in previous studies (Kupina,
Detloff et al. 2003; Hall, Detloff et al. 2004; Hall, Sullivan et al. 2005).

Tempol Preparation
Tempol was purchased from Sigma-Aldrich (Milwaukee, WI, U.S.A) and
freshly prepared in 0.9% saline before abdominal intraperitoneal (i.p.) injection. In
our dose-response study we experimented with different dosages at 3mg/kg,
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10mg/kg, 30mg/kg, 100mg/kg and 300mg/kg (n=8), which well covered the
dosage range that have been explored in related neuropathological studies and
pilot studies (Beit-Yannai, Zhang et al. 1996; Mota-Filipe, McDonald et al. 1999;
Behringer, Safar et al. 2002). Used as control for the tempol treatment group
(injured-tempol), 9% saline was given as vehicle to animals (injured-vehicle).
Another control group was composed of sham animal who were subjected to
craniotomy but no contusion injury and treated with vehicle (sham-vehicle). Sham
animals treated with tempol (n=8) in an initial dose-response study were also
tested, and indicated no difference from sham-vehicle group (data not shown).
There was zero mortality in the current study.

Tissue Extraction and Protein Assay
At the selected time points for the respective analysis (1 hr, 6 hrs, 12 hrs
or 24 hrs), the sham or injured-vehicle, injured-tempol mice were deeply
overdosed with sodium pentobarbital (200mg/kg i.p.). Following decapitation, the
ipsilateral cortical area of interest as was rapidly dissected on an ice-chilled stage
as previously described (Deng, Thompson et al. 2007). Immediately following
dissection, samples were transferred into pre-cooled Triton lysis buffer (1% triton,
20mM tris HCL, 150mM NaCl, 5mM EGTA, 10mM EDTA, 10% glycerol) with
protease inhibitors (Complete MiniTM Protease Inhibitor Cocktail tablet). Samples
were then briefly sonicated and vortexed at 14,000rpm for 30 minutes at 4°C,
and the supernatants were collected for protein assay. Protein concentration was
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determined by Bio-Rad DC Protein Assay, with sample solutions diluted to
contain 1mg/ml of protein for immunoblotting.

Slot-Blotting Analysis of Oxidative Damage (3NT)
To measure 3-nitrotyrosine (3NT), an aliquot of each ipsilateral cortical
protein (2µg) or isolated mitochondrial protein was diluted with 200µl of trisbuffered saline (TBS), and transferred to a Protran (0.2µm) nitrocellulose
membrane (Schleicher & Schuell, Dassel, Germany) by a Minifold II vacuum slot
blot apparatus (Schleicher & Schuell). After the samples were loaded into the
slots, they were allowed to filter through the membrane by gravity (no vacuum).
Each slot was then washed with 200µl TBS which was allowed to filter through
the membrane again. The membranes were then disassembled from the
apparatus, and incubated in a TBS blocking solution with 5% milk for 1 hr at
room temperature. For the detection of 3NT, a rabbit polyclonal anti-nitrotyrosine
antibody (Upstate Biotechnology, MA, USA) was used at a dilution of 1:2000 in
TBST blocking solution with 5% milk for overnight at 4°C. Preliminary
experiments established protein concentration curves in order to ensure that
quantified blots were in the linear range. From the results of these, we selected
the 2µg for use based upon that amount giving blots that were well within the
linear range. A standardized protein loading control was included on each blot to
normalize the band densities so that comparisons could be made across multiple
blots. All the samples were run in duplicate which were then averaged. For 3NT
analyses, no primary antibody controls were run to verify that the oxidative
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damage staining was specific. In addition, we ran positive controls using both
bovine serum albumin and normal brain tissue which were exposed to PN and
negative controls in which we pre-absorbed the primary antibodies with 3NT
which resulted in inhibition of the 3NT staining.

Mitochondrial Percoll Gradient Purification and BCA Protein Assay
Brain cortical mitochondria were extracted as previously described with
some modifications (Sullivan, Geiger et al. 2000; Sullivan, Dube et al. 2003).
Following decapitation, ipsilateral cortex was quickly removed and pooled from 3
mice. The cortices were placed in a Potter-Elvejhem homogenizer containing five
times the volume of ice-cold isolation buffer (5 fold buffer to tissue) with 1 mM
EGTA (215mM mannitol, 75mM sucrose, 0.1% BSA, 20mM HEPES, 1mM
EGTA; pH adjusted to 7.2 with KOH) and the homogenates were subjected to
differential centrifugation at 4°C. First, the homogenate was centrifuged twice at
1300 X g for 3 min in an Eppendorf microcentrifuge at 4°C to remove cellular
debris and nuclei. The pellet was discarded and the supernatant further
centrifuged at 13,000 X g for 10 min. The crude mitochondrial pellet obtained
after differential centrifugation were then subjected to nitrogen decompression to
release synaptic mitochondria, using a nitrogen cell disruption bomb, cooled to
4°C under a pressure of 1200 psi for 10 min (Sullivan, Dube et al. 2003; Brown,
Sullivan et al. 2004; Kristian, Hopkins et al. 2006). Following nitrogen disruption
the mitochondria were suspended in 3.5ml of 15% percoll and further laid on a
two preformed layers consisting of 3.5ml of 24% percoll and 3.5ml of 40% Percoll
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in 13ml ultra-clear tubes. The gradient was centrifuged in fixed angle rotor at
30,400 X g for 10 min at 4°C. The fraction accumulated at the interphase of 40%
and 24% percoll was carefully removed and diluted with isolation buffer without
EGTA, then centrifuged at 12,300 X g for 10 min at 4°C. The supernatants were
carefully removed, the pellet resuspended in isolation buffer without EGTA and
centrifuged at 13,000 X g for 10 min at 4°C. The mitochondrial pellets at the
bottom were then transferred to microcentrifuge tubes and topped off with
isolation buffer without EGTA and centrifuged at 10,000 X g for 5 min at 4°C to
yield a tighter pellet. The final mitochondrial pellet was resuspended in isolation
buffer without EGTA to yield a concentration of ~10mg/ml. The protein
concentration was determined using the BCA protein assay kit measuring
absorbance at 562 nm with a BioTek Synergy HT plate reader (Winooski,
Vermont).

Mitochondrial Respiration Measurement
Mitochondrial respiratory rates were measured using a Clark-type
electrode in a continuously stirred, sealed thermostatically-controlled chamber
(Oxytherm System, Hansatech Instruments Ltd) maintained at 37°C as
previously described (Sullivan, Geiger et al. 2000; Jiang, Sullivan et al. 2001;
Sensi, Ton-That et al. 2003; Sullivan, Dube et al. 2003). Twenty five to 40µg of
isolated mitochondrial protein was placed in the chamber containing 250µl of
KCl-based respiration buffer (125mM KCl, 2mM MgCl2, 2.5mM KH2PO4, 0.1%
BSA, 20mM HEPES at pH 7.2) and allowed to equilibrate for 1 min. This was
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followed by the addition of complex-I substrates, 5mM pyruvate and 2.5mM
malate, to monitor state II respiratory rate. Two boluses of 150µM ADP were
added to the mitochondria to initiate state III respiratory rate for 2 min followed by
the addition of 2µM oligomycin to monitor state IV respiration rate for an
additional 2 min. For the measurement of uncoupled respiratory rate, 2µM ptrifluoromethoxy carbonyl cyanide phenyl hydrazone (FCCP) was added to the
mitochondria in the chamber and oxygen consumption was monitored for another
2 min. This was followed by the addition of 10mM succinate to monitor complex
II-driven respiration. The respiratory control ratio (RCR) was calculated by
dividing state III oxygen consumption (defined as the rate of respiration in the
presence of ADP, second bolus addition) by the state IV oxygen consumption
(rate obtained in the presence of oligomycin). Fresh mitochondria were prepared
for each experiment and used within 4 hr.

Western-Blotting Analysis of Calpain-Mediated Cytoskeletal Degradation
To measure calpain-mediated α-spectrin proteolysis, aliquots of each
cortical sample (5µg) were run on a SDS/PAGE Precast gel (3-8% Tris-Acetate
CriterionTM XT Precast gel, Bio-Rad) and then transferred to a nitrocellulose
membrane using a semi-dry electro-transferring unit set at 15V for 15min.
Preliminary experiments established protein concentration curves in order to
ensure that quantified bands were in the linear range as measured with the LiCor Odyssey Infrared Imaging System. The membranes were incubated in a
TBS blocking solution with 5% milk for 1 hr at room temperature. For the
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detection of α-spectrin and its breakdown products, a mouse monoclonal anti-αspectrin antibody (Affiniti FG6090) was used at a dilution of 1:5000 in TBST
blocking solution with 5% milk for overnight at 4°C. A goat anti-mouse secondary
conjugated to an infrared dye (1:5000, IRDye800CW, Rockland) was then
applied for 1 hr at room temperature. After drying, the membranes were then
imaged and quantified using the Li-Cor Odyssey Infrared Imaging System. A
standardized protein loading control was included on each blot to normalize the
band densities so that comparisons could be made across multiple blots (Hall,
Sullivan et al. 2005). This was made up of pooled brain tissue protein collected
from previously run TBI mice which gave strong bands corresponding to the
280kD parent α-spectrin, the 150kD and the 145kD breakdown products. The
amount of protein in the loading control had been previously determined and
shown to be within the linear range as measured with the Li-Cor Odyssey
Infrared Imaging System.

Following the transfer, the gels were stained with

Coomassie Blue to verify even transfer. All the samples were run in duplicate and
averaged.

Statistical Analysis
For all of the time course analyses, we used Statview 5.0 to perform a
one-way analysis of variance (ANOVA), followed by Student-Newman-Keuls
(SNK) post-hoc analysis to determine the significance of differences between the
non-injured sham group and injured vehicle treated vs. injured tempol treated
groups. For the ANOVA, a p<0.05 was required to establish a statistically
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significant difference across the groups. However, for the post-hoc SNK analysis,
the program determined significance based upon a correction for multiple
comparisons.
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Results

Dose-Response Study of the Effect of Tempol on Protein Nitration
The level of protein nitration in cortical tissue homogenate was assessed
by quantitative antibody-based immuno-slotblotting. Figure 3.2 shows the results
of a dose-response analysis examining ipsilateral cortical protein nitration level
following TBI (n=8). Five different single i.p. dosages were administrated
abdominally to the mice 15 min after cortical contusion. All mice were euthanized
1 hr after when PN-induced oxidative is at its peak (Deng, Thompson et al.
2007). The ANOVA showed a significant difference across the experimental
groups [F(6,49)=3.397; p<0.01]. Post-hoc analysis revealed that the injured mice
treated with vehicle (0.9% saline) showed about 90% of increase in 3NT (a
specific marker for PN) level (p=0.007). In comparison to that, three highest
dosages of tempol (30mg/kg, 100mg/kg and 300mg/kg) significantly reduced the
3NT level comparing to injured mice treated with vehicle mice. However, there
was no significant difference among different dosage groups. The highest dose
of tempol treatment in the current study (300mg/kg) was able to completely
prevent any post-traumamtic increase in 3NT level over the sham baseline level.
Therefore, this dosage was chosen in the following studies. Another control
group, in which sham was treated with tempol (n=8) showed no difference from
sham vehicle-treated group (data not shown).
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Figure 3.2 Tempol treatment studies using quantitative slotblotting in ipsilateral
cortical traumatic brain injury tissues showing dose-response changes in protein
nitration (3-nitrotyrosin, 3NT). Single dose of tempol was administrated i.p. to
animals 15 min followed by sacrifice at 1 hr after TBI. The three highest doses at
30mg/kg, 100mg/kg and 300mg/kg significantly reduced 3NT level, a specific
marker for PN-induced oxidative damage, in ipsilateral cortical tissues. N = 8
animals per treatment group; values = mean + standard error; one-way ANOVA
and Student-Newman-Keuls post hoc test: A p < 0.01 vs. sham; one-way ANOVA
and Student-Newman-Keuls post hoc test: B p < 0.01 vs. vehicle.
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Effect of Tempol on Mitochondrial Respiration
Isolated cortical mitochondrial protein measured by BCA protein assay
was divided to run for mitochondrial respiratory assay and quantitative immunoslotblotting respectively (see Materials and Methods). Mitochondrial oxygen
consumption was measured by a Clarke-type electrode. In this study, mice (n=6)
were treated with a single i.p. dose either vehicle or tempol (300mg/kg) 15 min
after injury, followed by euthanasia 12 hrs after TBI. This time point was selected
since it we had previously shown that it represents the peak of mitochondrial
dysfunction in the CCI model (Singh, Sullivan et al. 2006a, see Appendix I).
Cortical mitochondria were isolated and purified followed by incubation in the
constantly-stirred sealed chamber. The oxygen consumption rate of each step
was recorded by the slope of the oxygen respiration trace upon substrates
addition. Figure 3.3A indicates the respiratory rates comparison among sham
vehicle-treated, injured vehicle-treated and injured tempol-treated groups. Two
doses of ADP after pyruvate and malate initiated the respiration of mitochondria.
There was a significant difference across the sham, injured vehicle and injured
tempol-treated groups [F(2,15)=4.339; p<0.05]. Post-hoc analysis showed that
injured vehicle-treated mitochondria displayed significantly decreased complex Idriven state III respiration compared to sham, indicating impaired mitochondrial
respiratory function. In contrast, the mitochondria isolated from the tempoltreated mice showed a complete maintenance of normal state III respiration
which was significantly higher than the vehicle-treated mice. There was no
significant difference detected in state IV respiration among groups upon
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oligomycin addition. The inhibition of ATP synthase generally eliminated most of
the respiratory activity.
A mitochondrial uncoupler, FCCP, was added to initiate maximal
mitochondrial respiration state V by inducing mild proton leak into mitochondria.
This analysis also showed a significant difference across the treatment groups
[F(2,15)=6.894; p<0.001]. Post-hoc testing showed that the injured vehicletreated group displayed significantly reduced respiration rate comparing to the
sham group, suggesting impairment of the electron transport chain (ETC).
However, mitochondria isolated from tempol-treated mice were able to show
significantly improved state V respiration compared to the vehicle-treated group.
Complex II-driven state VI respiration was tested by adding the complex II
substrate succinate. There was no significantly difference observed among three
treatment groups, suggesting that complex II and the downstream complexes
were relatively healthy, in contrast to complex I which was impaired.
Figure 3.3B displays the respiratory controlled ratio (RCR) of isolated
mitochondria from the three different treatment groups which the ANOVA showed
was significantly different [F(2,15)=11.910; p<0.001]. The RCR indicates how
well oxygen consumption is coupled to ATP generation and is often used as the
index of mitochondrial function (healthy: RCR>5). In Figure 3.3B, mitochondria
from injured mice without drug treatment shows a mean RCR=3.7, which was
significantly lower than the sham group, RCR=7.3. The tempol-treated group
demonstrated a mean RCR=5.6, suggesting that the mitochondria remain on
average within the healthy range (i.e. >5.0). The tempol treated mean was
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significantly higher than vehicle-treated group. However, although tempol
treatment was able to improve mitochondrial function to healthy level, the RCR in
the injured tempol-treated group was significantly lower than that in the sham
group, suggesting that mitochondrial function was not fully recovered.
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Figure 3.3 Effect of optimal single dose tempol treatment on mitochondrial
respiration in ipsilateral cortical traumatic brain injury tissues measured by
Clarke-type electrode. A. Single i.p. abdominal dose of tempol (300mg/kg)
significantly improved state III (ADP) and state V (FCCP) respiration comparing
to vehicle-treated group. B. Tempol treated group showed significant recovery of
respiratory controlled ration (RCR) comparing to vehicle-treated group. N = 6
animals per treatment group; values = mean + standard error; one-way ANOVA
and Student-Newman-Keuls post hoc test: A p < 0.05 vs. sham; one-way ANOVA
and Student-Newman-Keuls post hoc test: B p < 0.05 vs. vehicle.
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Effect of Tempol on Mitochondrial Oxidative Damage
Isolated cortical mitochondrial protein was measured by BCA protein
assay and 2µg of each sample was run on quantitative antibody-based immunoslotblots. Figure 3.4 demonstrates mitochondrial 3NT level at 12 hrs after injury
subjected to different treatments (n=4). The ANOVA revealed a significant
difference across the treatment groups [F(2,9)=4.843; p<0.05]. Post-hoc analysis
showed that even though the 3NT level in the injured vehicle-treated group was
increased comparing to sham group, this increase was not significant.
Consistent with this observation, we had previously found that while a significant
increase in 3NT level in mitochondrial proteins is seen as early as 30 min after
injury, and out to at least 3 hrs, the persistent mean increase in 3NT at 12 hrs
after TBI loses significance in comparison to sham (Singh, Sullivan et al. 2006a).
Nevertheless, in the injured tempol-treated group, 3NT level was significantly
lower than the injured vehicle-treated group by 55%. Moreover, the mean 3NT
level in the injured tempol-treated group was also lower than that seen in the
sham group, but this difference was not significant.
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Figure 3.4 Effect of optimal single dose tempol treatment on mitochondrial
oxidative damage in ipsilateral cortical traumatic brain injury tissues measured by
quantitative slotblotting. Single i.p. abdominal injection of tempol (300mg/kg)
significantly decreased 3NT level in comparison to vehicle-treated group in
cortical mitochondrial proteins. N = 4 animals per treatment group; values =
mean + standard error; one-way ANOVA and Student-Newman-Keuls post hoc
test: A p < 0.05 vs. sham; one-way ANOVA and Student-Newman-Keuls post hoc
test: B p < 0.05 vs. vehicle.
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Effect of Single Dose of Tempol on Calpain-Mediated α-Spectrin Breakdown
Post-traumatic cytoskeletal degradation was measured by antibody-based
immuno-westernblotting detecting α-spectrin breakdown products in cortical
tissues ipsilateral to the injury. Mice were treated with a single dose of vehicle or
tempol (300mg/kg) 15 min after TBI, and were killed at 1 hr or 6 hrs post-injury
(n=8/group). Figure 3.5A shows that there was statistically significant difference
across

the

three

groups

for

the

calpain-specific

SBDP145

analysis

[F(2,21)=5.590; p<0.05], but not in the case of the SBDP150 which is generated
by both calpain and caspase 3 (Wang 2000). Post-hoc testing revealed that there
was a significant increase in SBDP145 at 1 hr post-injury in the injured vehicletreated group compared to the sham vehicle-treated group. However, tempol
treatment significantly reduced SBDP145 compared to vehicle treatment by 45%.
Figure 3.5B displays the level of SBDPs at 6 hrs after TBI with or without
tempol treatment. Both SBDPs showed significant increase compared to the
sham group. Although there was a slight decline of both SBDPs in the injured
tempol-treated group compared to vehicle-treated group, the decrease was not
significant (p<0.01). The magnitude of both SBDPs in injury groups at 6 hrs postinjury was higher than that at 1 hr post-injury, which indicated there is
progressive increase of calpain activity over time following TBI until it reaches its
peak at 24 hrs in the CCI model (Deng, Thompson et al. 2007). The short term
effect of tempol in reducing SBDP145 at 1 hr but not 6 hrs post-injury
encouraged us to explore a tempol treatment regimen involving repeated doses
administered over the course of the oxidative damage.
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Figure 3.5 Effect of optimal single dose tempol treatment on calpain-mediated αspectrin breakdown in ipsilateral cortical traumatic brain injury tissues measured
by quantitative westernblotting. A. Tempol treatment significantly reduced
SBDP145 comparing to vehicle treatment, but here was no change in SBDP150
at 1 hr post-injury. B. Tempol treatment was not able to decrease SBDPs at 6 hrs
after TBI. N = 8 animals per treatment group; values = mean + standard error;
one-way ANOVA and Student-Newman-Keuls post hoc test: A p < 0.05 vs. sham;
one-way ANOVA and Student-Newman-Keuls post hoc test: B p < 0.05 vs.
vehicle.
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Effect of Multiple Dose of Tempol on Calpain-Mediated α-Spectrin Breakdown
In this study, multiple doses of vehicle or tempol (300mg/kg) were
administrated i.p. to mice at 15 min, 3 hrs, 6hrs, 9 hrs and 12 hrs post-injury
followed by euthanasia at 24 hrs when calpain-mediated SBDPs reach their peak
in the CCI model (Deng, Thompson et al. 2007). As indicated in Deng et al, at 24
hrs post-injury, the magnitude of calpain-specific SBDP145 is more than twice
as much as that of calpain/caspase 3-produced SBDP150, suggesting a the
dominant role of calpain in post-traumatic proteolysis. However, at 24 hrs postinjury the difference across groups for both SBDPs is significant; for SBDP145
[F(2,20)=16.513; p<0.0001] and for SBDP150 [F(2,20)=5.241; p<0.05] In Figure
3.6, tempol treatment decreased both SBDPs significantly compared to vehicle
treatment. The effect on SBDP150 was essentially complete since the magnitude
of non-specific SBDP150 is much lower than that of calpain-specific SBDP145.
However, although tempol treatment also reduced SBDP145 by 45% compared
to the injured vehicle-treated group, the SBDP145 level in the injured tempoltreated group remained significantly elevated compared to the sham level,
suggesting that proteolytic damage induced by calpain was not fully inhibited
even with this repeated dose treatment regimen.
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Figure 3.6 Effect of multiple dose tempol treatment on calpain-mediated αspectrin breakdown in ipsilateral cortical traumatic brain injury tissues measured
by quantitative westernblotting. Multiple doses of tempol were administrated at
15 min, 3 hrs, 6 hrs, 9 hrs and 12 hrs before sacrifice of the animals. In injured
vehicle-treated group, both SBDPs were significantly increased than sham group
with higher magnitude of SBDP145 elevation. Multiple i.p. injection of tempol
(300mg/kg) significantly reduced both SBDPs in comparison to vehicle-treated
group. N = 8 animals per treatment group; values = mean + standard error; oneway ANOVA and Student-Newman-Keuls post hoc test: A p < 0.05 vs. sham;
one-way ANOVA and Student-Newman-Keuls post hoc test: B p < 0.05 vs.
vehicle.
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Therapeutic Window of Multiple Dose of Tempol Treatment Measured by
Calpain-Mediated α-Spectrin Breakdown

A therapeutic window study next conducted in which the onset of tempol
multiple dose treatment was delayed from the 15 min post-injury tested earlier
(Figure 3.6 above) to either by 1 hr or 2 hrs. We administered multiple i.p. doses
treatment starting at 1 hr or 2 hrs post-injury, with four additional bolus i.p.
injections every 3 hrs. Animals were then studied at 24 hrs after the first injection.
In Figure 3.7A, a 1 hr delay in treatment with tempol showed no effect in both
SBDP145 and SBDP150. Both SBDPs remained at similar level as the injured
vehicle-treated group. Figure 3.7B displayed 2 hrs delay treatment of tempol,
which showed similar outcome. Although postponing the tempol treatment did not
show any protection, it did not exacerbate the post-traumatic cytoskeletal
proteolysis measured by calpain-mediated SBDPs.
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Figure 3.7 Therapeutic window study using multiple doses of tempol measured
by quantitative westernblotting. A. The multiple i.p. tempol treatment regimen
was postponed by 1 hr after injury, and animals were sacrificed at 25 hrs. B. The
multiple i.p. tempol treatment regimen was postponed by 2 hrs after injury, and
animals were sacrificed at 26 hrs. N = 8 animals per treatment group; values =
mean + standard error; one-way ANOVA and Student-Newman-Keuls post hoc
test: A p < 0.05 vs. sham; one-way ANOVA and Student-Newman-Keuls post hoc
test: B p < 0.05 vs. vehicle
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Discussion

The current study applied a pharmacological approach in elucidation of
the

pathophysiological

relationship

of

PN-induced

oxidative

damage,

mitochondrial dysfunction and calcium-activated, calpain-mediated cytoskeletal
degradation by testing the ability of the multi-mechanistic nitroxide antioxidant
tempol, to inhibit these secondary injury events in the CCI TBI mouse model.
Our previous time course study defined the dynamic changes of PN production,
oxidative

mitochondrial

damage,

calpain-mediated

proteolysis

and

neurodegeneration, and their temporal inter-relationship (Singh, Sullivan et al.
2006a, see Appendix I; Deng, Thompson et al. 2007). The time course study
strongly indicates that PN has a pivotal role in the secondary injury following TBI,
and suggests that scavenging of PN or its derived free radicals is a plausible
neuroprotective therapeutic target. A thorough analysis was conducted to
evaluate the therapeutic effect of tempol in regard to its ability to ameliorate
mitochondrial dysfunction and to preserve cytosolic Ca2+ homeostasis and as a
result to reduce calpain-mediated proteolysis.

Tempol Effect on PN-Mediated Oxidative Damage in the CCI-TBI Mouse Model
The neuroprotective effect of tempol was previously explored in a closed
head rat TBI model. Tempol showed cerebroprotective effects by limiting edema
formation, ameliorating blood-brain barrier (BBB) disruption and improving
functional recovery (Beit-Yannai, Zhang et al. 1996; Zhang, Shohami et al. 1998).
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In these studies, it was suggested that the neuroprotective effects of tempol was
due to its catalytic scavenging of superoxide radicals. However, oxidative
damage markers were not examined, and more recent experiments have
suggested that an important antioxidant property that may contribute significantly
to the inhibition of post-traumatic oxidative damage in brain tissue involves a
catalytic scavenging of the PN-derived radicals •NO2 and •CO3.
A stable biomarker of PN oxidative damage to proteins involves the
nitration of protein tyrosine residues which produces the product 3-nitrotyrosine
(3NT). Although it was previously suggested that nitric oxide (NO•) could give
rise to tyrosine nitration, subsequent analyses have shown that this is probably
caused by PN-derived •NO2. Alternatively, PN is able to react with SOD to form
nitronium ion (NO2+)-like intermediate which may also cause tyrosine residue
nitration (Ischiropoulos, Zhu et al. 1992). In the current study, we used antibodybased quantitative immuno-slotblotting detection of the PN-specific marker 3nitrotyrosine (3NT) to investigate the effect of tempol on PN-induced oxidative
damage. Animals were administered with single dose of tempol i.p. at 15 min and
sacrificed at 1 hr after injury when PN-induced oxidative damage is at its peak
(Deng, Thompson et al. 2007). A significant increase in cortical 3NT level in
vehicle treated group compared to sham was observed. Comparing to vehicle
treated group, tempol treatment 30mg/kg, 100mg/kg and 300mg/kg significantly
decreased 3NT level in the cortical tissue ipsilateral to the injury showing that
tempol has a wide range of antioxidant potency, and that scavenging of PNderived •NO2 may be key aspect of tempol’s antioxidant mechanism in vivo.
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Tempol Effect on Mitochondrial Respiration and Oxidative Damage in the CCITBI Mouse Model
Mitochondria have long been suggested to be a main resource for ROS.
The mono-electron transport through the mitochondrial ETC spins off oxidants
(mainly O2• ⎯ ) as by-products during metabolism (Shigenaga, Hagen et al. 1994;
Herrero and Barja 1997). Unknown components of ETC complex I and
ubiquinone of complex III are indicated to be the major sites of ROS generation.
It has been proposed that the complex I flavin mononucleotide (FMN) group was
the major ROS generating site (Liu, Fiskum et al. 2002), whereas others
hypothesize that mitochondrial generated O2• ⎯ preferably occurs at the lever of
coenzyme Q (Kowaltowski, Castilho et al. 1995). More recently, a novel Ca2+dependent isoform of nitric oxide synthase (NOS) was identified within
mitochondria which is activated upon mitochondrial Ca2+ uptake (Giulivi 1998;
Tatoyan and Giulivi 1998). Although NO• has been suggested to itself be toxic,
most investigators now believe that the damaging effects of NO• are mediated by
PN, which is formed by the diffusion rate-limited reaction of NO• with O2• ⎯
(Beckman and Koppenol 1996). Evidence has been obtained that the NO•dependent inactivation of iron-sulfur centers was in fact mediated by PN (Castro,
Rodriguez et al. 1994; Hausladen and Fridovich 1994). PN-derived radicals are
extremely reactive with bio-molecules, including lipids, proteins and DNAs
(Murphy, Packer et al. 1998; Radi 1998; Hall, Detloff et al. 2004). The discovery
of the mitochondrial isoform of NOS exposes mitochondria as the major source
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and therefore a target for PN-mediated oxidative damage (Packer and Murphy
1994).
Mitochondrial membrane integrity and compartmentalization is important
in maintaining normal respiratory function. However, high in content in
polyunsaturated fatty acids (PUFAs) makes brain mitochondria a vulnerable
target for free radicals attack and lipid peroxidation (LP). PN was reported to
increase mitochondrial proton leak but was irreversible by mPTP blocker,
cyclosporine A (CsA) (Brookes, Land et al. 1998). Echtay et al proposed that
4HNE, the end product of LP, acts as secondary messenger to induce proton
leak through uncoupling proteins (UCPs) and adenine nucleotide translocator
(ANT) (Echtay, Esteves et al. 2003). In additional to lipid damage, mitochondrial
proteins were indicated to be inactivated by oxidative damage in various
neurodegenerative diseases (Butterfield and Lauderback 2002; Gibson and
Huang 2004; Martin, Rosenthal et al. 2005). In a study in which mitochondria
were exposed to PN toxicity as well as Ca2+, the investigators observed the PNinduced membrane protein thiol cross-linking correlated to mitochondrial swelling
(Gadelha, Thomson et al. 1997). Moreover, proteomic identification of specific rat
mitochondrial fraction proteins demonstrated highly oxidized key components of
electron transport chain (ETC) 3 hrs after CCI (Opii, Nukala et al. 2007). In our
previous study, quantitative slotblotting measurement of post-injury mitochondrial
LP and protein nitration levels showed immediate increase of PN-induced
oxidative damage which persists for hours after injury (Singh, Sullivan et al.
2006a, see Appendix II). Although the level of 3NT in injured brain mitochondria
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is still elevated, it has lost significance by 12 hrs after injury due perhaps to its
decreased production and its possibly increased proteolytic removal (Grune,
Reinheckel et al. 1997). In the current study, we demonstrated that the early (15
min post-injury) tempol treatment largely reduced the 12 hrs post-injury cortical
mitochondrial 3NT level to below baseline, and significantly lower than the
vehicle-treated injured mitochondria. In correlation to reduced mitochondrial
oxidative damage, mitochondrial respiration was almost completely preserved
(Figure 3.3). Specifically, state III respiration in tempol-treated group shows full
preservation compared to the sham group, and the RCR (state III/state IV)
showed maintenance to within normal limits
The complex II-driven succinate respiration showed no significant
decrease after injury. Therefore, complex I-driven respiration possibly accounted
for most of the impaired respiratory function observed. Complex I is a very large
complex member with FMN redox center and many iron-sulfur centers. Hence it
is vulnerable to oxidative inactivation. Moreover, complexes I contains seven
mtDNA-encoded subunits out of the thirteen peptides encoded by mtDNA.
mtDNA is also a susceptible target for oxidative damage due to its proximity to
PN production and lack of histone protection. A recent study on CNS
mitochondria showed a correlation between the level of oxidized mtDNA bases
and post-traumatic impairment of respiration (Sullivan, Rabchevsky et al. 2004).
In any event, uncontrolled oxidative damage to mitochondrial membranes,
proteins and DNA can be detrimental to their function. Our studies showed that

99

administration of the membrane permeable tempol protects mitochondria against
oxidative damage and improves mitochondrial function at 12 hrs post-injury.

Tempol Effect on Calpain-Mediated α-Spectrin Breakdown in the CCI-TBI Mouse
Model
Calpain-mediated proteolysis has been implicated in many pathological
conditions. Evidences for mitochondrial damage and cytoskeletal proteolysis
coincide with calpain activity have been demonstrated in TBI models (Chan and
Mattson 1999; Wang 2000). Calpain, a cysteine protease, is activated in
response to cytosolic Ca2+ elevation. It was suggested that calpain plays a role in
dendritic remodeling, membrane repair and resealing and after injury (Faddis,
Hasbani et al. 1997). However, the disruption of neuronal Ca2+ homeostasis may
result in excessive activation of calpain (Saito, Elce et al. 1993; Bartus, Elliott et
al. 1995). In addition to that, a rat CCI model RT-PCR study revealed increased
mRNA expression of calpain and cysteine proteases within minutes after injury
that persisted for days post-injury (Ringger, Tolentino et al. 2004). Moreover,
calpain has a similar temporal profile as caspases, and responses to different
injury severities even though calpain responds to a greater degree (Thompson,
Gibson et al. 2006; Deng, Thompson et al. 2007). Because of its extensive
involvement in ischemia and traumatic neuronal injuries, calpain-mediate
proteolysis is proposed as a final common pathway of neuronal cell death
following various insults (Bartus, Elliott et al. 1995; Bartus, Dean et al. 1998).
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Dramatic upregulation of calpain activity progresses for hours after injury,
which provides a broad temporal opportunity for neuroprotection (Saatman,
Graham et al. 1998; Deng, Thompson et al. 2007). Our previous work (Chapter 2
and Deng, Thompson et al. 2007) showed that post-traumatic calpain activation
and cytoskeletal proteolysis is preceded by PN-mediated oxidative damage,
mitochondrial dysfunction, impairment of Ca2+ homeostasis and presumably
intracellular Ca2+ overload and is then followed by neurodegeneration. If these
processes are indeed linked as a series of events, then tempol treatment, which
is known to interfere with the initiating PN-induced oxidative damage and
mitochondrial dysfunction, should also attenuate the downstream calpainmediated proteolytic damage to cellular elements. We first tested this hypothesis
through single i.p. dose tempol treatment administered immediately after CCI
which showed an inhibitory effect on calpain activity at 1 hr post-injury. We
accordingly conclude that the membrane permeable tempol is rapidly taken up by
mitochondria where it prevents their oxidative damage and loss of Ca2+ buffering
capacity leading to an attenuation of intracellular Ca2+ overload and prevention of
calpain over-activation. However, when we waited until 6 hrs after injury, this
protective effect observed at 1 hr was no longer apparent in the case of early
single dose tempol treatment. This is probably due to the fact that tempol has a
very short half-life in mice (<30 min) (Kamatari, Yasui et al. 2002). Furthermore,
the high blood flow in cortical tissue will hasten its elimination from the injured
brain tissue following a single dose.
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Subsequently, we administered multiple dosages of tempol at 3 hrs
intervals up to 12 hrs and measured its effect at 24 hrs after injury. This
experiment showed that this more aggressive multiple dose tempol treatment
had a partial inhibitory effect on calpain-mediated proteolysis. However, the
therapeutic window for the achievement of this effect is disappointingly short
since delayed initiation of tempol treatment until 1 or 2 hrs post-injury failed to
attenuate the 24 hrs peak of calpain-mediated α-spectrin degradation. This result
may indicate that even though PN-induced oxidative damage is a critical early
event in post-TBI injury, the potential therapeutic practicality of its inhibition is
limited by a short therapeutic time window.
Alternatively, it is now well known that that oxidative stress has inhibitory
effects on both calpain (Benuck, Banay-Schwartz et al. 1992; Guttmann, Elce et
al. 1997; Guttmann and Johnson 1998) and caspase 3 (Lau, Arundine et al.
2006) via oxidation of cysteine residues at the active site. Accordingly, total
inhibition of ROS may remove the protective aspect of free radicals which may
serve to reduce post-traumatic calpain activation together with the attenuation in
oxidative damage to the mitochondria. This dual effect of ROS in this case, may
be seen in the biphasic increase time course of α-spectrin degradation we
observed which is similar to that seen in different experimental models in vitro
and in vivo neural injury (Neumar, Meng et al. 2001; DeRidder, Simon et al.
2006; Xiong, Rabchevsky et al. 2007). As shown by our previous study, there
was a biphasic increase of SBDPs connected by a plateau phase between 3 hrs
and 12 hrs. Between 12 hrs and 24 hrs, both SBDPs exhibited a greater than
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75% elevation (Deng, Thompson et al. 2007). The sudden and significant
increase in SBDPs began at 12 hrs which represented the outer limit of the
measurable increase in PN-mediated 3NT (Figure 2.4). Thus, the wave of
oxidative damage occurring between 30 min and 12 hrs post-injury while
detrimental to the injured tissue overall may at the same time serve to limit the
full expression of calpain activation. This two-edged sword in regards to the
influence of PN on calcium-induced activation of calpain may explain why at best
tempol is only partially effective at attenuating cytoskeletal degradation even
when given soon after TBI. It may also help explain why tempol has an
apparently very short therapeutic window in relation to inhibiting downstream
proteolytic damage. In other words, if tempol is delayed until calpain activation is
more established, the removal of the oxidative attenuation of calpain activity may
lead to an exacerbation of calpain activity that may offset the benefits of the
tempol reduction in mitochondrial oxidative damage. Further experiments are
needed to investigate this notion. In any event, it seems clear that antioxidant
treatment may need to be combined with other agents that more directly target
calpain activation in order to achieve a more pronounced and practical
neuroprotective approach. Copyright © Ying Deng 2007.
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Chapter Four
Effect of Tempol on Behavioral Recovery and Neurodegeneration after
Traumatic Brain Injury

Introduction

Every year in the United States an estimated 1.5 to 2 million people
sustain traumatic brain injury (TBI). Despite the progress in diagnostics and
surgical treatments and rehabilitation care, most patients suffer from persistent
physical

and

psychological

impairments.

An

efficacious

neuroprotective

compound is yet to be developed in TBI clinical trails to prevent secondary
neurodegeneration and chronic neurological functional impairment. The primary
mechanical TBI leads to secondary neural cell damage and cell death which is
proportional to the degree of cognitive or sensory and motor dysfunction.
Immediate post-traumatic neurochemical changes begin immediately after injury.
(Katayama, Becker et al. 1990) which include widespread cellular depolarization
and massive release of the excitatory neurotransmitter, glutamate, resulting in
calcium (Ca2+) influx through ion channels associated with glutamate receptors.
Moreover, the disruption in cellular Ca2+ homeostasis leading to intracellular
overload is to multiple cytotoxic events including ROS production, mitochondrial
dysfunction,

and

Ca2+-dependent

protease

activation

as

indicated

in

experimental TBI models (Young 1992; Azbill, Mu et al. 1997). As indicated in
our previous experiments study using the CCI mouse model, the production of
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the reactive oxygen species (ROS) peroxynitrite (PN), is an early immediate
post-traumatic event that appears to lead to mitochondrial damage and functional
failure and calpain over-activation (Chapter2; Deng et al, 2007). Moreover, we
have shown that early administration of the multi-mechanistic nitroxide
antioxidant tempol within the first 15 min post-injury can reduce post-traumatic
PN-mediated oxidative damage, maintain mitochondrial function and lessen
calpain-mediated cytoskeletal degradation. In the current study, we investigated
the effect of early tempol to improve neurological recovery and reduce
neurodegeneration during the first 7 days in the mouse severe controlled cortical
impact (CCI) TBI model.
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Materials and Methods

All the surgical, injury and animal care protocols described below have
been approved by the University of Kentucky Institutional Animal Care and Use
Committee, and are consistent with the animal care procedures set forth in the
guidelines of the U.S. Public Health Service Policy on Humane Care and Use of
Laboratory Animals.

Mouse Model of Controlled Cortical Impact (Focal) Traumatic Brain Injury
Young adult male CF-1 mice (Charles River, Portage, MI) weighing 2931g were used in this study. The mice were anesthetized with isoflurane (3.0%),
shaved, and then placed in a stereotaxic frame (David Kopf Instruments,
Tujunga, CA). Throughout the surgery, the mice were provided with constant
isoflurane (SurgiVet, 100 Series) and oxygen (SurgiVet, O2 flowmeter, 0-4Lpm).
The head was positioned in the horizontal plane of a stereotaxic frame with the
nose bar set at zero. We firstly produced a 4mm craniotomy lateral to the sagittal
suture, and centered between lambda and bregma. A cortical contusion was
produced on the exposed cortex (the anterior-posterior coordinate for the
epicenter of the injury was Bregma -2.0mm) using a pneumatically-controlled
impactor device (Precision System Instruments TBI-0200 Impactor, Lexington,
KY) similar to that previously described (Sullivan, Bruce-Keller et al. 1999;
Sullivan, Thompson et al. 1999; Hall, Sullivan et al. 2005) except that the current
device utilizes a unique contact sensor mechanism that ensures accurate and
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reliable determination of cortical surface prior to initiating the injury sequence.
This results in increased accuracy and reproducibility in regards to the CCI injury
compared to that produced by earlier CCI impactors. In the present studies, the
impactor containing a 3mm diameter rod tip compressed the cortex at 3.5m/sec
to a depth of 1mm with a dwell time of 50msec to produce a severe injury. After
surgery and injury, a 4mm disk made from dental cement (Dentsply Trubyte) was
placed over the craniotomy site and adhered to the skull using cyanoacrylate. In
order to prevent immediate post-traumatic hypothermia, following the suturing of
the skin, mice were placed in a Hova-Bator incubator (37˚C, model 1583, Randall
Burkey Co) until them regained consciousness (determined by the regain of the
righting reflex and increased mobility). The injured mice were allowed to survive
from 7 days. The N for each time point group was 12 animals based upon our
experience with the variability seen with these measurements in previous studies
(Kupina, Detloff et al. 2002; Hall, Sullivan et al. 2005).

Tempol Preparation
Tempol was purchased from Sigma-Aldrich (Milwaukee, WI, U.S.A) and
freshly prepared in 0.9% saline before abdominal intraperitoneal (i.p.) injection.
Animals were administered five i.p. dosages of tempol at 300mg/kg according to
our dose-response study at 15 min, 3 hrs, 6 hrs, 9 hrs and 12 hrs. Used as
control to tempol treatment group (injured-tempol), 9% saline was given as
vehicle to animals (injured-vehicle). Another control group involved sham animal
with craniotomy but no contusion injury, which was as well treated with vehicle
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(sham-vehicle). Sham animals treated with tempol (n=12) in the dose-response
study was tested, and indicated no difference from sham-vehicle group (data not
shown). There was zero mortality in the current study.

Neuroscore Behavioral Test
The neuroscore test was used to assess the neurological status of the
sham and TBI mice at 48 hrs and 7 days post-injury. This test is modified from
previously described series of tests used for assessing the effects of TBI in the
rat (McIntosh, Vink et al. 1989), and adapted for mouse (Murai, Pierce et al.
1998; Raghupathi, Fernandez et al. 1998). In the present study, we employed the
neuroscore with three components: grid walk (front limb and hind limb), cagetop
(front limb and hind limb) and lateral pulsion. In preliminary experiments we
documented that the neuroscore test was able to detect motor deficit induced by
injury after either moderate (0.5 mm) or severe (1.0 mm) CCI TBI. In each
component, the animal can receive a total of 4 points for a maximum high of 12
points. Gridwalk: In this component, the mice are forced to walk on a metal
gridwalk and timed for 1 min. An observer, who is unaware of the mouse
treatment groups, observes the left vs. the right limb 1) for a greater number of
slips on the right side than the left; 2) for more profound slips on the right side as
apposed to the left. The animal can lose a maximum of 1 point for the front and
1 point for the hind limb for this portion of the motor assessment. Cagetop: In the
second neuroscore component, there are total of 3 points that the mice can lose
for visible deficits in hind limb and front limb function each. For hind limb
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functional assessment, the animal is held by the head and the tail above the grid
and and then slowly moved down toward the grid as the observer assesses the
hind limbs for toe splay as well as hind limb extension. For front limb functional
impairment measurement, the animal is suspended by the tail and lowered
toward the cage top until he can grab the rungs of the cage top during which he
is determined how well he extends his arms. Lateral pulsion: For the third
component of the neuroscore test, the animal is placed on a rubber mat, making
sure its body is parallel to the corrugations on the mat. He is then slowly pushed
back and forth the entire width of the mat. This is done twice slowly to prime the
animal. After these two practice trials, the first trial is started with a slow push
(same speed as for the practice trials) and then accelerated for each subsequent
trial up to 4 trials. Four points are deducted if the animal rolls at the 1st trial, 3
points at the 2nd trial, 2 points at the 3rd trial and 1 point at the 4th trial. The animal
gains all points if he does not roll after 4 trials.

De Olmos Silver Staining Analysis of Neurodegeneration
Following the completion of the 7 days post-injury neuroscore test,
neurodegeneration was examined using the de Olmos aminocupric silver
histochemical technique as previously described (de Olmos, Beltramino et al.
1994; Switzer 2000; Hall, Gibson et al. 2005; Hall, Sullivan et al. 2005). At 7
days the mice (N=12) were overdosed with sodium pentobarbital (200mg/kg i.p)
and transcardially perfused with 0.9% sodium chloride, followed by a fixative
solution containing 4% paraformaldehyde.
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Following decapitation, the heads

were stored in a fixative solution containing 15% sucrose for 24 hrs after which
the brains were removed, placed in fresh fixative and shipped for histological
processing to Neuroscience Associates Inc (Knoxville TN). The brains used for
this study were embedded into one gelatin block (Multiblock® Technology,
Neuroscience Associates). The block was then frozen and thirteen 35µm coronal
sections were taken 420µm apart between 1.1mm anterior and 4.4mm posterior
to bregma, were de Olmos silver-stained to reveal degenerating neurons and
neuronal processes, and then counterstained with Nuclear Fast Red. The brain
sections were photographed on an Olympus Provis A70 microscope at 1.25×
magnification using an Olympus Magnafire digital camera and the image was
analyzed by Image-Pro Plus (4.0). The percentage area of silver staining for
each brain section was calculated by dividing the area of ipsilateral hemispheric
silver staining in each section by the area of the contralateral hemispheric area
and multiplying by 100. The volume of silver staining in the ipsilateral hemisphere
as a percentage of the contralateral hemispheric volume was estimated by the
equation % V = t × Σ % a(s), where % V is percent silver stain volume, t = the
distance between sections analyzed (420µm) and Σ % a (s) is the sum of percent
area of silver staining in all sections examined (13 for each brain) (Hall, Sullivan
et al. 2005).

Lesion Volume Measurement
In addition to measuring the volume of neurodegeneration with the
DeOlmos silver staining method, the brain sections were photographed on an
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Olympus Provis A70 microscope at 1.25× magnification using an Olympus
Magnafire digital camera and the lesion volume was analyzed by ImageJ 1.37v
(NIH) (Michel and Cruz-Orive 1988; Sullivan, Thompson et al. 2000; Pandya,
Pauly et al. 2007). The percentage area of ipsilateral cortical tissue spared for
each brain section was calculated by dividing the area in each section by the
area of the contralateral cortex and multiplying by 100. The volume of the
ipsilateral cortical spared tissue as a percentage of the contralateral cortical
volume was estimated by the sum of percent area of spared tissue of all sections
multiplied by the distance between sections analyzed.

Statistical Analysis
For treatment group analyses, we used Statview 5.0 to perform a one-way
analysis of variance (ANOVA), followed by Student-Newman-Keuls (SNK) posthoc analysis to determine the significance of differences between individual the
non-injured sham group and injured vehicle treated vs. injured tempol treated
groups. For multiple section analyses, we used Statview 5.0 to perform an
ANOVA repeated measurement, followed by Student-Newman-Keuls (SNK)
post-hoc analysis to determine the significance of differences between individual
sections in the non-injured sham group and injured vehicle treated vs. injured
tempol treated groups. For the ANOVA, a p<0.05 was required to establish a
statistically significant difference across the groups. However, for the post-hoc
SNK analysis, the program determined significance based upon a correction for
multiple comparisons comparing among groups.
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Results

Behavioral Outcome Measured by Neuroscore Motor Test after Tempol
Treatment
Five i.p. dosages of tempol (300mg/kg each; last dose at 12 hrs after
injury) were administered to the animals at a three hours intervals beginning at
15 min following the CCI injury. Behavioral outcome was assessed at 48 hrs and
7 days after TBI respectively measured by neuroscore. We divided the scores
into fore limb and hind limb two categories. At 48 hrs after injury (Figure 4.1), the
ANOVA revealed a significant difference across the treatment groups in both fore
limb [F(2,33)=3.610; p<0.05] and hind limb [F(2,33)=3.927; p<0.05] motor
function. Post-hoc analysis showed that the motor function in injured vehicletreated group was significantly impaired compared to the scores of the sham
group. Although the 48 hrs fore limb and hind limb scores for the injured tempoltreated group were not significantly different from the injured vehicle-treated
group, the scores of the tempol-treated group were also not significantly lower
than the sham group implying some improvement in the 48 hrs neurological
status as a result of tempol treatment started at 15 min post-injury. At 7 days
after

injury,

both

fore

limb

[F(2,33)=2.668;

p=0.0843]

and

hind

limb

[F(2,33)=2.797; p=0.0755] motor function showed no significant difference
among treatment groups. Although injured vehicle-treated animals showed
decreased scores comparing to sham group, this slight deficit was not statistically
significant.
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Figure 4.1 Behavioral outcome of multiple dose tempol treatment measured by
neuroscore motor test after TBI. Neuroscore was accessed at 48 hrs and 7 days
after injury. N = 12 animals per treatment group; values = mean + standard error;
one-way ANOVA and Student-Newman-Keuls post hoc test: A p < 0.05 vs. sham;
one-way ANOVA and Student-Newman-Keuls post hoc test:
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Histological

Evaluation

of

Neurodegeneration

Measured

by

de

Olmos

Aminocupric Silver Staining after Tempol Treatment
Following the 7 day neuroscore test, the brains were harvested for
histopathological analysis of neurodegeneration. Figure 4.2 displays the degrees
of cortical tissue sparing (4.2A) and hemispheric neurodegeneration (4.2B) in
injured, vehicle-treated and injured tempol-treated animals. Figure 4.2A
measured the spared tissue in vehicle-treated vs. tempol-treated animals. The
area of spared tissue in ipsilateral cortex was outlined and calculated as
percentage of the area of contralateral cortex. In Figure 4.2A, tempol-treated
group showed 5% improvement in spared cortical tissue volume compared to
vehicle-treated group, however, the increase was not quite significant. Using the
de Olmos aminocupric silver staining method, we are able to measure
degenerating tissue in the entire ipsilateral hemisphere plus the ipsilateral lesion
volume. In Figure 4.2B, both injured groups displayed a significant increase in
neurodegeneration silver staining volume compared to sham group. However,
the injured tempol-treated group showed significantly reduced neurodegeneration
compared to injured vehicle-treated group [F(2,33)=125.864; p<0.05]. In Figure
4.2C, selected coronal brain section in the epicenter displayed the improvement
in tissue sparing as well as the reduction in the volume of neurodegenerationrelated silver staining with tempol treatment vs. vehicle treatment.
Figure 4.3 shows the percentage of silver staining in coronal brain
sections from the anterior hemispheric boundary of the post-traumatic
neurodegeneration to the posterior boundary. Injured groups at all sections
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showed a significant increase of silver staining compared to the sham group. The
injured, tempol-treated group displayed significantly less silver staining than
injured vehicle-treated group at section 28, which is in the epicenter of the injury.
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Figure 4.2 Histological evaluation of multiple dose tempol treatment on tissue
sparing and silver staining in ipsilateral hemisphere after TBI. A. Tissue sparing
at 7 days after injury showed slight increase in tempol treatment group, however,
not significant. B. Silver staining at 7 days after injury indicated significant
reduction of silver staining in tempol treatment group. C. Selected coronal brain
sections in the epicenter from different treatment groups. N = 12 animals per
treatment group; values = mean + standard error; one-way ANOVA and StudentNewman-Keuls post hoc test: A p < 0.05 vs. sham; one-way ANOVA and
Student-Newman-Keuls post hoc test: B p < 0.05 vs. vehicle.
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Figure 4.3 Histological evaluation of multiple dose tempol treatment on coronal
brain section silver staining in ipsilateral hemisphere after TBI. Silver staining at 7
days after injury indicated significant reduction of silver staining in tempol
treatment group at coronal section 28. N = 12 animals per treatment group;
values = mean + standard error; repeated measures ANOVA and StudentNewman-Keuls post hoc test: A p < 0.05 vs. sham; repeated measuers ANOVA
and Student-Newman-Keuls post hoc test: B p < 0.05 vs. vehicle.
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Discussion

In the current study, we tested the hypothesis that tempol, by scavenging
ROS,

preserving

mitochondrial

function

and

reducing

calpain-mediated

proteolysis (Chapter 3) could reduce post-traumatic neurological impairment and
neurodegeneration. There is compelling evidence for the key role of ROSinduced oxidative damage in the secondary injury in TBI models (Kontos and
Povlishock 1986; Kontos and Wei 1986; Hall, Andrus et al. 1993; Hall, Andrus et
al. 1994; Smith, Andrus et al. 1994; Globus, Alonso et al. 1995). Most convincing
is the fact that several antioxidant compounds have been shown to be
neuroprotective in TBI models (Hall and Smith 1991; Marshall, Maas et al. 1998;
Mori, Kawamata et al. 1998; Marklund, Lewander et al. 2001). However, most
antioxidants are targeting one specific free radical and react stoichiometrically.
As indicated in our first study (Chapter 2), PN is probably the key mediator
in post-traumatic oxidative damage, which is the main source for both lipid
peroxidation and protein nitration (Deng, Thompson et al. 2007). Tempol, a PNderived free radical scavenger, is a membrane permeable, catalylic antioxidant,
which was shown to react promptly with hydroxyl radical, nitrogen dioxide and
carbonate radical (Carroll, Galatsis et al. 2000; Bonini, Mason et al. 2002).
Moreover, PN as an upstream factor in the secondary injury cascade, we proved
that tempol was able to inhibit oxidative damage, ameliorate mitochondrial
dysfunction and decrease calpain-mediated cytoskeletal degradation at least
when administered during the first 15 min post-injury. Therefore, in the present

118

study, we further examined the ability of tempol to exert a definitive
neuroprotective effect in terms of a reduction in neurological impairment and
neurodgeneration.
We applied de Olmos aminocupric silver staining in this study to measure
neurodegeneration. Comparing to conventional histological staining used in
many pathohistological studies, the silver staining method is much more sensitive
in detection of injured neurons and axons in response to TBI (de Olmos,
Beltramino et al. 1994; Switzer 2000). At 7 days after injury, severe cavitation
has developed at the epicenter of the contusion. However, silver staining
revealed subcortical tissue damage widespread to ipsilateral hippocampus and
dorsolateral thalamus. Moreover, silver staining disclosed commissural fiber
damage extended to the contralateral site to the injury. Therefore, silver staining
is able to detect cellular damage that is not measured by conventional
histological staining. Spared tissue volume showed no significant difference
between vehicle and tempol treatment. However, measurement of silver staining
revealed a significant, but rather modest reduction in neurodegeneration after
tempol treatment.
Despite the improvement in overall neurodegeneration, there was no
significant functional recovery after the tempol treatment measured by
neuroscore at 7 days after injury. The current neuroscore motor test was
examined in a pilot study. At 48 hrs and 72 hrs after severe (1.0mm) and
moderate (0.5mm) CCI in mouse, animals showed significant deficit comparing to
sham animals (data not shown). At 48 hrs, severe TBI mice displayed further
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impairment than moderate TBI mice. However, at 72 hrs, both severe and
moderate TBI mice scored similarly. In the current study, we accessed the
neuroscore of the mice at 48 hrs and 7 days respectively. The deficit was
detectable in both fore limb and hind limb motor function at 48 hrs after injured
with vehicle treatment, but not at 7 days. Nevertheless, the tempol treatment did
appear to exert some improvement in neurological recovery at the 48 hrs time
point. Although the tempol group did not manifest a significant difference
compared to the neuroscore of the vehicle treatment group, neither the fore limb
nor the hind limb functional scores were significantly differently from sham group
in contrast to the significantly lower scores in the injured, vehicle-treated mice
compared to the sham group. This suggested that motor function was somewhat
improved with the tempol treatment. At 7 days after injury, we accessed the
neuroscore again. However, scores in all groups were similar and there was no
significant difference among groups. We suspect that the current neuroscore test
may not be suitable for long-term behavioral evaluation. In any event, the
beneficial effects of tempol also demonstrated previously in a rat TBI model (BeitYannai, Zhang et al. 1996; Zhang, Shohami et al. 1998) and in cerebral ischemia
models (Rak, Chao et al. 2000; Leker, Teichner et al. 2002) are consistent with
the view that the compound possesses demonstrable neuroprotective properties
in CNS injury models, in general.
There may be multiple reasons for the modest effect of tempol. First of all,
the testing of tempol for its ability to reduce calpain-mediated cytoskeletal
degradation which was assessed at 24 hrs after injury (Chapter 3), showed a
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statistically

significant

45%

reduction

in

calpain-mediated

cytoskeletal

degradation. We suspect that the partial inhibition of calpain-mediated proteolysis
is part of the reason why tempol did not have more pronounced effect in
preserving

neuronal

tissue.

Secondly,

in

the

present

experiments,

neurodegeneration was not examined until 7 days after injury rather than at its
peak which is 48 hrs post-injury (Chapter 2; Deng, Thompson et al. 2007). This
was done so that we could assess neurological status out to 7 days before
performing histopathology. However, the 7 day time point where less silver
staining is seen compared to the 48 hrs peak may make it more difficult to
observe a more robust neuroprotective effect. Thirdly, as noted in Chapter 3, the
half life of tempol in mice is fairly short (i.e. <30 min) (Kamatari, Yasui et al. 2002)
and therefore even repeated dosing with the compound is unable to maintain
therapeutic levels adequately during the first 12 hrs post-injury. Other longeracting PN-directed antioxidants may be more effective due to the ability to
maintain a steady, non-fluctuating radical scavenging effect. Lastly, even though
PN-mediated oxidative damage is an important player in the secondary injury
process, a more complete neuroprotective effect may require simultaneously
blocking the secondary injury cascade at multiple points downstream from the
early oxidative damage with a mitochondrial protective agent and/or a direct
inhibitor of calpain.
Concerning the latter option, the principle pathological role of calpainmediated proteolysis is demonstrated in secondary neuronal cell death (Buki,
Siman et al. 1999; Povlishock, Buki et al. 1999; Kupina, Detloff et al. 2003; Hall,

121

Sullivan et al. 2005). Calpain is a calcium-dependent protease and is triggered in
response to massive calcium influx following TBI (Saatman, Graham et al. 1998;
Kupina, Detloff et al. 2003; Serbest, Burkhardt et al. 2007). Immuno-detection of
structural protein spectrin, which is a substrate for calpain, showed calpianmediated proteolysis in damaged axons (Roberts-Lewis, Savage et al. 1994). In
addition to spectrin, other structural proteins, such as microtubule associated
proteins (MAPs) and neurofilaments (NFs) are also substrates for calpain, and
are associated with axonal damage (Maxwell, Povlishock et al. 1997; Okonkwo,
Pettus et al. 1998). Therefore, calpain is a logical therapeutic target for
pharmacological inhibition in combination with an antioxidant in order to more
completely prevent post-traumatic neurodegeneration. Indeed, several calpain
inhibitors administered either prior to or after CNS injury (Saatman, Murai et al.
1996; Kupina, Nath et al. 2001; Kupina, Detloff et al. 2002; Buki, Farkas et al.
2003) have been shown to improve post-traumatic neurological recovery and
tissue sparing.
In conclusion, despite the possibly limited therapeutic potential of tempol
by itself, the protective efficacy of the compound is at least adequate to support
our original hypothesis that PN-mediated oxidative damage is an upstream posttraumatic event that contributes to mitochondrial dysfunction, intracellular Ca2+
overload, calpain-mediated cytoskeletal degradation and neurodegeneration as
illustrated in Figure 4.4. Copyright © Ying Deng 2007.
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Tempol

Tempol

Figure 4.4 Hypothetical interrelationship between PN-induced oxidative damage
in neuronal mitochondria and the compromise of Ca2+ homeostasis, calpainmediated proteolysis and neurodegeneration. Our results suggest that the potent
antioxidant, tempol, by targeting the upstream PN-derived free radicals, produces
cascades of effects on the downstream cellular elements, such as preserve
mitochondrial function, ameliorate Ca2+ overload, reduce calpain-mediated
proteolysis and neurodegeneration.
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Chapter Five
Summary and Conclusions

Traumatic brain injury (TBI) is comprised of the primary injury and
secondary injury. The initial mechanical assault to the head induces instant
tissue damage, which is termed the primary injury. However, the primary injury
induces cascades of neurochemical changes, which lead to further neuronal cell
loss, microvascular damage and dysfunction and impairment in behavioral
function. Secondary injury begins immediately after injury, and this post-injury
phase may last for days and weeks depending on the severity of the initial injury.
Although little can be done to reduce the primary injury apart from decreasing the
risk of TBI, it is feasible to ameliorate post-TBI secondary injury by timely
pharmacological intervention. Thus, understanding pathological mechanisms
responsible

for

post-traumatic

neuronal

damage

will

shed

light

on

neuroprotective pharmaceutical approaches.
Successful pharmacological interventions for TBI patients are not
available to this day due in large part to the complexity of the neurological
changes initiated by the primary injury. In this series of studies, we employed a
widely used focal TBI model, controlled cortical impact (CCI) mouse model. The
current project has identified peroxynitrite (PN) as an important therapeutic target
for pharmacological intervention. Moreover, we explored the effect of PN-derived
radical scavenger, tempol, on PN-induced oxidative damage, mitochondrial
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dysfunction, calpain-mediated proteolysis, neurodegeneration and neurological
outcome.
The first study is a thorough comparative time course assessment of PNinduced

oxidative

damage,

calpain-mediated

α-spectrin

breakdown

and

neurodegeneration measured by de Olmos aminocupric silver staining in
ipsilateral cortex in the CCI mouse model. Both quantitative slotblotting and
immunohistochemical studies indicate that PN is the main source of lipid
peroxidation and protein nitration, suggesting that PN is an important mediator of
post-traumatic oxidative damage. The onset of PN-mediated oxidative damage
measured in cerebral cortical tissue begins immediately after injury and peaks at
1 hr after injury. This is coincident with an increase of oxidative damage in
cortical mitochondria, suggesting that mitochondria are perhaps the main source
and target of post-traumatic production of PN. Furthermore, quantitative
westernblotting measured calpain-mediated cytoskeletal degradation which is
also increased within the first hours after injury. The increased appearance of
calpain-mediated spectrin breakdown (SBDPs) progresses over time and
reaches its peak at 24 hrs. Calpain-specific SBDP145 showes a much higher
magnitude than non-specific calpain/caspase 3-generated SBDP150, indicating
that calpain is the main mediator in post-traumatic proteolysis. Moreover, the
peak of calpain-mediated cytoskeletal breakdown precedes the peak of
neurodegeneration, which is at 48 hrs after injury.
The time course study elegantly illustrated the interrelationship of several
key mediators following TBI. The early increase of PN production correlates with
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mitochondrial dysfunction. As a key calcium buffer in the cell, the loss of
mitochondrial function exacerbates Ca2+-dependent calpain activity, and
eventually neuronal cell loss. The quantitative measurement of the end products
of oxidative damage and calpain-mediated proteolysis also provides measurable
index for therapeutic studies. More importantly, the complete temporal profile of
oxidative damage, calpain activity and neurodegeneration defines the probable
time windows for pharmacological intervention. These results reveal that PN is
an upstream event that precedes mitochondrial dysfunction, calpain overactivation and neurodegeneration. Therefore, targeting PN-induced oxidative
damage may have multiple beneficial effects through inhibition of several key
mediators in the secondary injury process. However, the extremely early peak of
oxidative damage also makes it a difficult target. Timely treatment is critical in
therapeutic interventions. Based on the time course study, we chose the optimal
time point of each end point for neuroprotective effect evaluation.
To test the hypothesis that blockade of upstream PN-induced oxidative
damage will produce a neuroprotective effect, we pharmacologically targeted PN
using a potent antioxidant, tempol, in the CCI model. Tempol is a membrane
permeable, catalytic scavenger of PN-derived free radicals. In an initial study, we
examined the dose-response of tempol in regards to an inhibitory effect on PNinduced oxidative damage across a three log range of dosages (3, 10, 30, 100
and 300mg/kg i.p.). We chose the PN-specific marker, 3-nitrotyrosine (3NT), as
an index to examine the effect of tempol on PN-induced oxidative damage. In
order to achieve maximal effect, tempol was administered i.p. at 15 min and
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tissue was harvested at 1 hr post-injury when oxidative damage is at its peak.
Our results show that tempol inhibited PN-mediated oxidative damage in a doserelated manner with the highest dose levels of 30, 100 and 300mg/kg each
producing a statistically significant effect. Moreover, quantitative slotblotting
measurement of 3NT indicated that at 300mg/kg, tempol reduces 3NT to sham
level. This study demonstrated that tempol is an effective inhibitor of PNmediated oxidative damage in the injured brain.
Following the success of tempol in inhibition of PN-induced oxidative
damage, we chose the optimal dose (300mg/kg) of tempol in the subsequent
studies to confirm our hypothesis that oxidative damage is the upstream element
in the secondary injury cascade. We hypothesizes that mitochondria are the main
source of PN production based upon previous studies in our laboratory showing
that PN-mediated damage occurs in mitochondria from the injured brain which
parallels the loss of respiratory function and Ca2+-buffering capacity. Indeed, in
response to glutamate-induced excitotoxic calcium influx, mitochondrial Ca2+
uptake induces superoxide and nitric oxide radical production, which can
combine with a diffusion rate-limited rate constant to produce PN. To test the
association between mitochondrial PN oxidative damage and respiratory
dysfunction, we administered tempol 15 min after injury and isolated the
mitochondria from the injured cerebral cortex at 12 hrs post-injury. Using Clarketype electrode measurement of mitochondrial respiration, tempol-treated
mitochondria show improved maintenance of respiratory function together with
reduced oxidative protein damage. The protective effect of tempol on
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mitochondrial function reveals that: 1) tempol is membrane permeable and
effective in penetrating into mitochondrial matrix; 2) mitochondria are a main
source for PN production as well as the primary target of PN-mediated oxidative
damage. Moreover, the success of using tempol in vivo to preserve mitochondrial
function, strongly suggests that PN plays a significant role in mediating
mitochondria calcium influx-induced functional impairment.
Moving downstream in the hypothesized secondary injury cascade, we
examined the effect of tempol on calcium-dependent calpain activity. Calpain is
activated upon calcium influx and is shown to play an important role in
cytoskeletal degradation, which is considered as a final common pathway to cell
death. Because of the close relationship of calpain and cytosolic calcium level,
we hypothesize that tempol, by preserving mitochondrial function and
maintaining calcium homeostasis, will indirectly attenuate calpain activity. To test
this hypothesis, we administered single i.p. dose of tempol 15 min after injury and
evaluated calpain-mediated SBDPs at 1 hr and 6 hrs post-injury measured by
quantitative slotblotting. The results demonstrate that tempol significantly
reduces calpain-specific SBPD145 at 1 hr but not at 6 hrs after injury. The
inhibitory effect of antioxidant tempol on calpain-mediated cytoskeletal
proteolysis strongly confirms that PN-induced oxidative damage is upstream to
calpain over-activation. However, the effect of tempol on calpain activity is shortlived possibly due to the high elimination rate of tempol in the mouse brain.
Therefore, we explored the effect of a multiple dose regimen with tempol on
calpain-mediated cytoskeletal degradation. In the tempol multiple dose
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experiment, we administered tempol 300 mg/kg i.p. to animals at 15 min, 3 hrs, 6
hrs, 9 hrs and 12 hrs post-injury and harvested the tissue at 24 hrs, when
calpain-mediated SBDPs are at their peak. This dosing regimen was designed to
maintain an inhibition of PN-mediated oxidative damage over its full time course
of 12 hrs based upon our original time course studies. Our results show tempol
significantly reduces SBDPs by 45% at 24 hrs post-injury. Although the
prolonged treatment with tempol may have successfully inhibited most of the
oxidative damage, the inhibition of calpain activity was only partial. A possible
explanation is that PN itself has inhibitory effect on both calpain and caspase 3
by oxidizing cysteine residues on their active site. Therefore, the complete
inhibition of PN may partially antagonize the full expression of its protective
benefits via a removal of an oxidative break on calpain activity.
We then did a tempol therapeutic window study by measuring calpainmediated SBDPs. We used the same multiple dosing regimen, but delayed
treatment by 1 hr and 2 hrs. In this study, we are not able to observe any
beneficial effect of tempol on calpain inhibition. It is possible that the first hour
window is crucial for PN-induced oxidative damage and tempol alone may not be
able to induce maximal inhibition on calpain activity.
We have successfully proven that by preventing upstream PN-induced
oxidative damage, we can ameliorate mitochondrial dysfunction and attenuate
calpain-mediated cytoskeletal degradation, which is linked to cell injury and
death. Therefore, we applied the multiple dosing regimen and examined the
neurodegeneration at 7 days after injury. In this study, we measured ipsilateral
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cortical tissue spared volume and ipsilateral hemispherical silver staining volume.
Tempol treatment increases cortical tissue sparing. However, this effect is not
significant compared to vehicle-treated group. In contrast, silver staining detected
a significant decrease in neurodegeneration in tempol-treated group. In the
tempol-treated group, the extent of the silver staining is reduced. We believe that
silver staining is a much more sensitive technique that more accurately reveals
the degree of post-traumatic tissue damage and more sensitively shows the
efficacy of neuroprotective agents.
In this last study, we examined the behavioral outcome in parallel with the
neurohistological study. Specifically, we measured motor function of the TBI mice
at 48 hrs and 7 days post-injury. At 48hrs, we observed a deficit in motor function
in the injured vehicle-treated animals. However, the mean score of the tempoltreated animals is not significantly different from either the non-injured sham
group or vehicle-treated group. At 7 days, the neuroscore is not able to detect
any difference among the groups suggesting that future studies should focus on
the earlier 48 hrs time point. Moreover, a more sensitive functional test, or a
combination of different behavioral assessment, such as cognitive as well as
motorsensory testing, should be considered in the future.
In summary, the complete time course study and the pharmacological
study compliments each other, and provide strong evidence for PN-induced
oxidative damage being an important upstream mediator in the secondary cell
death cascade. In our study, scavenging PN-derived free radicals with the
nitroxide antioxidant tempol produces beneficial effects on mitochondrial function
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and probably calcium buffering capacity which in turn reduces downstream
calpain-mediated proteolysis and neurodegeneration. However, the complexity of
the secondary injury process after TBI challenges the idea that single therapy
can achieve optimal neuroprotection and improvement in functional outcome. In
the future, it will make sense to investigate combination therapies that
simultaneously target PN-induced oxidative damage along with either inhibition of
mitochondrial permeability transition or calpain activation or both. Copyright ©
Ying Deng 2007.
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Appendix I

Figure A.1 Time course of mitochondrial states III & IV respiratory rates in
mouse ipsilateral cortex after severe (1.0mm) TBI. Mitochondrial oxygen
consumption was measured using a Clark-type electrode in a continuously
stirred, sealed chamber (Oxygraph System; Hansatech Instruments Ltd). Purified
mitochondrial protein (25 to 35 µg) was suspended in respiration buffer
(125mmol/L KCl, 2mmol/L MgCl2, 2.5mmol/L KH2PO4, 0.1% BSA, 20mmol/L
HEPES, pH7.2) in a final volume of 250µl. Data are presented as mean ± s.e.m.
Statistical differences (one-way ANOVA and Student-Neuman-Keuls post hoc
test): * P<0.0001 versus sham; # P<0.001 versus sham.
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Appendix II

Figure A.2 Time course of lipid (HNE) and protein (protein carbonyl) oxidative
damage in percoll-purified mitochondria from the ipsilateral cortex after a severe
(1.0mm) TBI. Distribution of HNE, protein carbonyls, and 3NT in cortical
mitochondria from mice at 30 min, 3 and 12 hrs after injury and were compared
with sham (3 hrs) animals. Approximately 2.5µg of percoll-purified mitochondrial
protein isolated from cortical region was applied onto Protran nitrocellulose
membrane (Schleicher & Schuell, Dassel, Germany), as described in Materials
and Methods, and oxidative markers were quantitated using a Minifold II
vacuum slot blot apparatus. Data are presented as mean ± s.e.m. Statistical
differences (one-way ANOVA and SNK post hoc test): * P<0.05 versus sham;
P<0.001 versus sham; *** P<0.0001 versus sham; @ P<0.005 versus sham.
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Appendix III
Glossary of important terms
∆Ψm
∆pH
3NT
4HNE
8-OH-G
8-OHdG
ADP
AIF
ANT
ASDH
ATP
BBB
BDPs
Ca2+
CCI
CNS
CsA
CypD
Cyt c
DNPH
eNOS
ETC
FADH2
FCCP
FMNH2
FPI
GPX
GSH
HPLC
IMM

mitochondrial membrane
potential
proton force
3-nitrotyrosin
4-hydroxynonenal
8-hydroxyguanine
8hydroxydeoxyguanosine
adenosine diphosphate
apoptosis inducing factor
adenine nucleotide
translocator
subdural hematoma
adenosine triphosphate
blood-brain barrier
breakdown products
calcium
controlled cortical impact
central nervous system
cyclosporine A
cyclophilin D
cytochrome c
2,4dinitrophenylhydrazine
epithelial nitric oxide
synthase
electron transport chain
reduced flavin adenine
dinucleotide
p-trifluoromethoxy
carbonyl cyanide phenyl
hydrazone
reduced flavin
mononucleotide
fluid percussion injury
glutathione peroxidase
glutathione
high-performance liquid
chromatography
inner mitochondrial
membrane

iNOS
L-DOPA

LP
NADPH
nNOS
MAP2
MDA
mPTP
MPTP
mtNOS
NADH
NADPH

NF
NMDA
NO
NOS
ONOO•
ONOO⎯
ONOOH
ONOOCO2
PARS
PBS
PGH
PN
PUFAs
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inducible nitric oxide
synthase
dihydroxyphenylalanine
lipid peroxidation
nicotinamide adenine
dinucleotide phosphate,
reduced form
neuronal nitric oxide
synthase
microtubule-associated
proteins
malondialdehyde
mitochondrial
permeability transition
pore
1-methyl-4-phenyl-1,2,5,6
tetrahydropyridine
mitochondrial nitric oxide
synthase
nicotinamide adenine
dinucleotide, reduced
form
nicotinamide adenine
dinucleotide phosphate,
reduced form
neurofilament
N-Methyl-D-aspartate
nitric oxide
nitric oxide synthas
peroxynitrite anion
peroxynitrite anion
peroxynitrite acid
nitrosoperoxo carbonate
ADP-ribose synthetase
phosphate-buffered
saline
prostaglandin
hydroperoxidase
peroxynitrite
polyunsaturated fatty
acids

RCR
ROS
RNS
SBDPs
SCI
SOD
XO
TAI
TBI
TBS
UCPs
UQ
UQ• ⎯
UQH2
XDH
XO

respiratory control ratio
reactive oxygen species
reactive nitrogen species
α-spectrin breakdown
products
spinal cord injury
superoxide dismutase
xanthine oxidase
traumatic axonal injury
traumatic brain injury
tris-buffered saline
uncoupling proteins
ubiquinone
semiquinone anion
species
ubiquinol
xanthine dehydrogenase
xanthine oxidase
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